| 1001 | ADI-SPA-807PE-F | HSP60 monoclonal antibody (LK-2) (PE conjugate) | 200 µg |
| 1002 | ADI-SPA-810-488-D | HSP70/HSP72 monoclonal antibody (C92F3A-5) (DyLight™ 488 conjugate) | 50 µg |
| 1003 | ADI-SPA-810-488-F | HSP70/HSP72 monoclonal antibody (C92F3A-5) (DyLight™ 488 conjugate) | 200 µg |
| 1004 | ADI-SPA-810AP-D | HSP70/HSP72 monoclonal antibody (C92F3A-5) (AP conjugate) | 50 µg |
| 1005 | ADI-SPA-810AP-F | HSP70/HSP72 monoclonal antibody (C92F3A-5) (AP conjugate) | 200 µg |
| 1006 | ADI-SPA-810B-D | HSP70/HSP72 monoclonal antibody (C92F3A-5) (biotin conjugate) | 50 µg |
| 1007 | ADI-SPA-810B-F | HSP70/HSP72 monoclonal antibody (C92F3A-5) (biotin conjugate) | 200 µg |
| 1008 | ADI-SPA-810-D | HSP70/HSP72 monoclonal antibody (C92F3A-5) | 50 µg |
| 1009 | ADI-SPA-810-F | HSP70/HSP72 monoclonal antibody (C92F3A-5) | 200 µg |
| 1010 | ADI-SPA-810FI-D | HSP70/HSP72 monoclonal antibody (C92F3A-5) (FITC conjugate) | 50 µg |
| 1011 | ADI-SPA-810FI-F | HSP70/HSP72 monoclonal antibody (C92F3A-5) (FITC conjugate) | 200 µg |
| 1012 | ADI-SPA-810-J | HSP70/HSP72 monoclonal antibody (C92F3A-5) | 1 mg |
| 1013 | ADI-SPA-810PE-D | HSP70/HSP72 monoclonal antibody (C92F3A-5) (PE conjugate) | 50 µg |
| 1014 | ADI-SPA-810PE-F | HSP70/HSP72 monoclonal antibody (C92F3A-5) (PE conjugate) | 200 µg |
| 1015 | ADI-SPA-811-D | HSP70/HSP72 polyclonal antibody | 50 µg |
| 1016 | ADI-SPA-811-F | HSP70/HSP72 polyclonal antibody | 200 µg |
| 1017 | ADI-SPA-812-D | HSP70/HSP72 polyclonal antibody | 50 µg |
| 1018 | ADI-SPA-812-F | HSP70/HSP72 polyclonal antibody | 200 µg |
| 1019 | ADI-SPA-812-J | HSP70/HSP72 polyclonal antibody | 1 mg |
| 1020 | ADI-SPA-8131-D | HSP70/HSP72 monoclonal antibody (N31F2-4) | 50 µg |
| 1021 | ADI-SPA-8131-F | HSP70/HSP72 monoclonal antibody (N31F2-4) | 200 µg |
| 1022 | ADI-SPA-8132-D | HSP70/HSP72 monoclonal antibody (C96F3-3) | 50 µg |
| 1023 | ADI-SPA-8132-F | HSP70/HSP72 monoclonal antibody (C96F3-3) | 200 µg |
| 1024 | ADI-SPA-8133-D | HSP70/HSP72 monoclonal antibody (N15F2-5) | 50 µg |
| 1025 | ADI-SPA-8133-F | HSP70/HSP72 monoclonal antibody (N15F2-5) | 200 µg |
| 1026 | ADI-SPA-8134-D | HSP70/HSP72 (human) monoclonal antibody (N21F3-2) | 50 µg |
| 1027 | ADI-SPA-8135-D | HSP70/HSP72 (human) monoclonal antibody (N33F3-4) | 50 µg |
| 1028 | ADI-SPA-8135-F | HSP70/HSP72 (human) monoclonal antibody (N33F3-4) | 200 µg |
| 1029 | ADI-SPA-8136-D | HSP70/HSP72 monoclonal antibody (N6F3-6.140) | 50 µg |
| 1030 | ADI-SPA-8136-F | HSP70/HSP72 monoclonal antibody (N6F3-6.140) | 200 µg |
| 1031 | ADI-SPA-815-488-E | HSC70/HSP73 monoclonal antibody (1B5) (DyLight™ 488 conjugate) | 100 µg |
| 1032 | ADI-SPA-815B-D | HSC70/HSP73 monoclonal antibody (1B5) (biotin conjugate) | 50 µg |
| 1033 | ADI-SPA-815B-F | HSC70/HSP73 monoclonal antibody (1B5) (biotin conjugate) | 200 µg |
| 1034 | ADI-SPA-815-D | HSC70/HSP73 monoclonal antibody (1B5) | 50 µg |
| 1035 | ADI-SPA-815-F | HSC70/HSP73 monoclonal antibody (1B5) | 200 µg |
| 1036 | ADI-SPA-815-J | HSC70/HSP73 monoclonal antibody (1B5) | 1 mg |
| 1037 | ADI-SPA-815PE-E | HSC70/HSP73 monoclonal antibody (1B5) (PE conjugate) | 100 µg |
| 1038 | ADI-SPA-816-D | HSC70/HSP73 polyclonal antibody | 50 µg |
| 1039 | ADI-SPA-816-F | HSC70/HSP73 polyclonal antibody | 200 µg |
| 1040 | ADI-SPA-816-J | HSC70/HSP73 polyclonal antibody | 1 mg |
| 1041 | ADI-SPA-817-D | HSC70 (plant) monoclonal antibody (5B7) | 50 µg |
| 1042 | ADI-SPA-817-F | HSC70 (plant) monoclonal antibody (5B7) | 200 µg |
| 1043 | ADI-SPA-818-D | HSC70 (plant) monoclonal antibody (1D9) | 50 µg |
| 1044 | ADI-SPA-818-F | HSC70 (plant) monoclonal antibody (1D9) | 200 µg |
| 1045 | ADI-SPA-819-D | HSC70/HSP73 polyclonal antibody | 50 µg |
| 1046 | ADI-SPA-819-F | HSC70/HSP73 polyclonal antibody | 200 µg |
| 1047 | ADI-SPA-820-488-E | HSC70/HSP70 monoclonal antibody (N27F3-4) (DyLight™ 488 conjugate) | 100 µg |
| 1048 | ADI-SPA-820AP-D | HSC70/HSP70 monoclonal antibody (N27F3-4) (AP conjugate) | 50 µl |
| 1049 | ADI-SPA-820AP-F | HSC70/HSP70 monoclonal antibody (N27F3-4) (AP conjugate) | 200 µl |
| 1050 | ADI-SPA-820-D | HSC70/HSP70 monoclonal antibody (N27F3-4) | 50 µg |
| 1051 | ADI-SPA-820-F | HSC70/HSP70 monoclonal antibody (N27F3-4) | 200 µg |
| 1052 | ADI-SPA-820PE-D | HSC70/HSP70 monoclonal antibody (N27F3-4) (PE conjugate) | 50 µg |
| 1053 | ADI-SPA-820PE-F | HSC70/HSP70 monoclonal antibody (N27F3-4) (PE conjugate) | 200 µg |
| 1054 | ADI-SPA-822-D | HSC70/HSP70 monoclonal antibody (BB70) | 50 µg |
| 1055 | ADI-SPA-822-F | HSC70/HSP70 monoclonal antibody (BB70) | 200 µg |
| 1056 | ADI-SPA-826-D | Grp78/BiP polyclonal antibody | 50 µg |
| 1057 | ADI-SPA-826-F | Grp78/BiP polyclonal antibody | 200 µg |
| 1058 | ADI-SPA-826-J | Grp78/BiP polyclonal antibody | 1 mg |
| 1059 | ADI-SPA-827-488-D | KDEL monoclonal antibody (10C3) (DyLight™ 488 conjugate) | 50 µg |
| 1060 | ADI-SPA-827-488-F | KDEL monoclonal antibody (10C3) (DyLight™ 488 conjugate) | 200 µg |
| 1061 | ADI-SPA-827-D | KDEL monoclonal antibody (10C3) | 50 µg |
| 1062 | ADI-SPA-827-F | KDEL monoclonal antibody (10C3) | 200 µg |
| 1063 | ADI-SPA-827-J | KDEL monoclonal antibody (10C3) | 1 mg |
| 1064 | ADI-SPA-828-D | HSP60 polyclonal antibody | 50 µg |
| 1065 | ADI-SPA-828-F | HSP60 polyclonal antibody | 200 µg |
| 1066 | ADI-SPA-828-J | HSP60 polyclonal antibody | 1 mg |
| 1067 | ADI-SPA-829-D | HSP60 monoclonal antibody (Mab11-13) | 50 µg |
| 1068 | ADI-SPA-829-F | HSP60 monoclonal antibody (Mab11-13) | 200 µg |
| 1069 | ADI-SPA-830-488-D | HSP90 monoclonal antibody (AC88) (DyLight™ 488 conjugate) | 50 µg |
| 1070 | ADI-SPA-830-488-F | HSP90 monoclonal antibody (AC88) (DyLight™ 488 conjugate) | 200 µg |
| 1071 | ADI-SPA-830-D | HSP90 monoclonal antibody (AC88) | 50 µg |
| 1072 | ADI-SPA-830-F | HSP90 monoclonal antibody (AC88) | 200 µg |
| 1073 | ADI-SPA-830-J | HSP90 monoclonal antibody (AC88) | 1 mg |
| 1074 | ADI-SPA-830PE-D | HSP90 monoclonal antibody (AC88) (PE conjugate) | 50 µg |
| 1075 | ADI-SPA-830PE-F | HSP90 monoclonal antibody (AC88) (PE conjugate) | 200 µg |
| 1076 | ADI-SPA-831-050 | HSP90 monoclonal antibody (2D11B9) | 50 µg |
| 1077 | ADI-SPA-831-200 | HSP90 monoclonal antibody (2D11B9) | 200 µg |
| 1078 | ADI-SPA-835B-E | HSP90 monoclonal antibody (16F1) (biotin conjugate) | 100 µg |
| 1079 | ADI-SPA-835-D | HSP90 monoclonal antibody (16F1) | 50 µg |
| 1080 | ADI-SPA-835-F | HSP90 monoclonal antibody (16F1) | 200 µg |
| 1081 | ADI-SPA-836-D | HSP90 polyclonal antibody | 50 µg |
| 1082 | ADI-SPA-836-F | HSP90 polyclonal antibody | 200 µg |
| 1083 | ADI-SPA-839-050 | HSP90α monoclonal antibody (K41009) | 50 µg |
| 1084 | ADI-SPA-839-200 | HSP90α monoclonal antibody (K41009) | 200 µg |
| 1085 | ADI-SPA-839PE-0050 | HSP90α monoclonal antibody (K41009) (PE conjugate) | 50 µg |
| 1086 | ADI-SPA-839PE-0200 | HSP90α monoclonal antibody (K41009) (PE conjugate) | 200 µg |
| 1087 | ADI-SPA-840-D | HSP90α monoclonal antibody (9D2) | 50 µg |
| 1088 | ADI-SPA-840-F | HSP90α monoclonal antibody (9D2) | 200 µg |
| 1089 | ADI-SPA-840HRP-D | HSP90α monoclonal antibody (9D2) (HRP conjugate) | 50 µg |
| 1090 | ADI-SPA-840HRP-F | HSP90α monoclonal antibody (9D2) (HRP conjugate) | 200 µg |
| 1091 | ADI-SPA-840-J | HSP90α monoclonal antibody (9D2) | 1 mg |
| 1092 | ADI-SPA-840PE-0050 | HSP90α monoclonal antibody (9D2) (PE conjugate) | 50 µg |
| 1093 | ADI-SPA-840PE-0200 | HSP90α monoclonal antibody (9D2) (PE conjugate) | 200 µg |
| 1094 | ADI-SPA-842-D | HSP90β monoclonal antibody (K3705) | 50 µg |
| 1095 | ADI-SPA-842-F | HSP90β monoclonal antibody (K3705) | 200 µg |
| 1096 | ADI-SPA-843-D | HSP90β monoclonal antibody (K3701) | 50 µg |
| 1097 | ADI-SPA-843-F | HSP90β monoclonal antibody (K3701) | 200 µg |
| 1098 | ADI-SPA-844-050 | HSP90β polyclonal antibody | 50 µg |
| 1099 | ADI-SPA-844-200 | HSP90β polyclonal antibody | 200 µg |
| 1100 | ADI-SPA-844PE-050 | HSP90β polyclonal antibody (PE conjugate) | 50 µg |
| 1101 | ADI-SPA-844PE-200 | HSP90β polyclonal antibody (PE conjugate) | 200 µg |
| 1102 | ADI-SPA-845-D | HSP90 monoclonal antibody (2D12) | 50 µl |
| 1103 | ADI-SPA-845-F | HSP90 monoclonal antibody (2D12) | 200 µl |
| 1104 | ADI-SPA-846-D | HSP90 polyclonal antibody | 50 µg |
| 1105 | ADI-SPA-846-F | HSP90 polyclonal antibody | 200 µg |
| 1106 | ADI-SPA-850-488-D | Grp94 monoclonal antibody (9G10) (DyLight™ 488 conjugate) | 50 µg |
| 1107 | ADI-SPA-850-488-F | Grp94 monoclonal antibody (9G10) (DyLight™ 488 conjugate) | 200 µg |
| 1108 | ADI-SPA-850-D | Grp94 monoclonal antibody (9G10) | 50 µg |
| 1109 | ADI-SPA-850-F | Grp94 monoclonal antibody (9G10) | 200 µg |
| 1110 | ADI-SPA-850PE-D | Grp94 monoclonal antibody (9G10) (PE conjugate) | 50 µg |
| 1111 | ADI-SPA-850PE-F | Grp94 monoclonal antibody (9G10) (PE conjugate) | 200 µg |
| 1112 | ADI-SPA-851-D | Grp94 polyclonal antibody | 50 µg |
| 1113 | ADI-SPA-851-F | Grp94 polyclonal antibody | 200 µg |
| 1114 | ADI-SPA-860-D | Calnexin polyclonal antibody | 50 µg |
| 1115 | ADI-SPA-860-F | Calnexin polyclonal antibody | 200 µg |
| 1116 | ADI-SPA-865-D | Calnexin polyclonal antibody | 50 µg |
| 1117 | ADI-SPA-865-F | Calnexin polyclonal antibody | 200 µg |
| 1118 | ADI-SPA-880-D | DnaK (<i>E. coli</i>) monoclonal antibody (8E2/2) | 50 µg |
| 1119 | ADI-SPA-880-F | DnaK (<i>E. coli</i>) monoclonal antibody (8E2/2) | 200 µg |
| 1120 | ADI-SPA-880-J | DnaK (<i>E. coli</i>) monoclonal antibody (8E2/2) | 1 mg |
| 1121 | ADI-SPA-881-D | HSP65 (mycobacterial) monoclonal antibody (3F7) | 50 µl |
| 1122 | ADI-SPA-881-F | HSP65 (mycobacterial) monoclonal antibody (3F7) | 200 µl |
| 1123 | ADI-SPA-882-E | HSP65 (mycobacterial) monoclonal antibody (4H11) | 100 µg |
| 1124 | ADI-SPA-885-J | HSP71 (mycobacterial) monoclonal antibody (5A8) | 1 mg |
| 1125 | ADI-SPA-890-D | PDI polyclonal antibody | 50 µg |
| 1126 | ADI-SPA-890-F | PDI polyclonal antibody | 200 µg |
| 1127 | ADI-SPA-891-488-D | PDI monoclonal antibody (1D3) (DyLight™ 488 conjugate) | 50 µg |
| 1128 | ADI-SPA-891-488-F | PDI monoclonal antibody (1D3) (DyLight™ 488 conjugate) | 200 µg |
| 1129 | ADI-SPA-891-D | PDI monoclonal antibody (1D3) | 50 µg |
| 1130 | ADI-SPA-891-F | PDI monoclonal antibody (1D3) | 200 µg |
| 1131 | ADI-SPA-891-J | PDI monoclonal antibody (1D3) | 1 mg |
| 1132 | ADI-SPA-891PE-D | PDI monoclonal antibody (1D3) (PE conjugate) | 50 µg |
| 1133 | ADI-SPA-891PE-F | PDI monoclonal antibody (1D3) (PE conjugate) | 200 µg |
| 1134 | ADI-SPA-894-D | HO-1 polyclonal antibody | 50 µg |
| 1135 | ADI-SPA-894-F | HO-1 polyclonal antibody | 200 µg |
| 1136 | ADI-SPA-895-D | HO-1 polyclonal antibody | 50 µg |
| 1137 | ADI-SPA-895-F | HO-1 polyclonal antibody | 200 µg |
| 1138 | ADI-SPA-895-J | HO-1 polyclonal antibody | 1 mg |
| 1139 | ADI-SPA-896-D | HO-1 polyclonal antibody | 50 µg |
| 1140 | ADI-SPA-896-F | HO-1 polyclonal antibody | 200 µg |
| 1141 | ADI-SPA-896-J | HO-1 polyclonal antibody | 1 mg |
| 1142 | ADI-SPA-897-D | HO-2 polyclonal antibody | 50 µg |
| 1143 | ADI-SPA-897-F | HO-2 polyclonal antibody | 200 µg |
| 1144 | ADI-SPA-901-D | HSF1 polyclonal antibody | 50 µg |
| 1145 | ADI-SPA-901-F | HSF1 polyclonal antibody | 200 µg |
| 1146 | ADI-SPA-901-J | HSF1 polyclonal antibody | 1 mg |
| 1147 | ADI-SPA-902-D | [pSer<sup>326</sup>]HSF1 polyclonal antibody | 50 µg |
| 1148 | ADI-SPA-902-F | [pSer<sup>326</sup>]HSF1 polyclonal antibody | 200 µg |
| 1149 | ADI-SPA-950-D | HSF1 monoclonal antibody (10H8) | 50 µg |
| 1150 | ADI-SPA-950-F | HSF1 monoclonal antibody (10H8) | 200 µg |
| 1151 | ADI-SPA-960-E | HSF2 monoclonal antibody (3E2) | 100 µg |
| 1152 | ADI-SPA-970-0050 | TRAP1 polyclonal antibody | 50 µg |
| 1153 | ADI-SPA-970-0200 | TRAP1 polyclonal antibody | 200 µg |
| 1154 | ADI-SPA-971-0050 | TRAP1 monoclonal antibody (9B6) | 50 µg |
| 1155 | ADI-SPA-971-0200 | TRAP1 monoclonal antibody (9B6) | 200 µg |
| 1156 | ADI-SPP-110-D | Cpn10 (human), (recombinant) | 50 µg |
| 1157 | ADI-SPP-110-F | Cpn10 (human), (recombinant) | 200 µg |
| 1158 | ADI-SPP-225-J | α-Crystallin (bovine), (native) | 1 mg |
| 1159 | ADI-SPP-225-L | α-Crystallin (bovine), (native) | 5 mg |
| 1160 | ADI-SPP-226-D | αA-Crystallin (bovine), (native) | 50 µg |
| 1161 | ADI-SPP-226-F | αA-Crystallin (bovine), (native) | 200 µg |
| 1162 | ADI-SPP-227-D | αB-Crystallin (bovine), (native) | 50 µg |
| 1163 | ADI-SPP-227-F | αB-Crystallin (bovine), (native) | 200 µg |
| 1164 | ADI-SPP-228-050 | αB-Crystallin (human), (recombinant) (His-tag) | 50 µg |
| 1165 | ADI-SPP-228-200 | αB-Crystallin (human), (recombinant) (His-tag) | 200 µg |
| 1166 | ADI-SPP-229-050 | αA-Crystallin (human), (recombinant) (His-tag) | 50 µg |
| 1167 | ADI-SPP-229-200 | αA-Crystallin (human), (recombinant) (His-tag) | 200 µg |
| 1168 | ADI-SPP-236-F | βL-Crystallin (bovine), (native) | 200 µg |
| 1169 | ADI-SPP-236-J | βL-Crystallin (bovine), (native) | 1 mg |
| 1170 | ADI-SPP-240-J | γ-Crystallin (bovine), (native) | 1 mg |
| 1171 | ADI-SPP-400-D | HSP40/Hdj1 (human), (recombinant) | 50 µg |
| 1172 | ADI-SPP-400-F | HSP40/Hdj1 (human), (recombinant) | 200 µg |
| 1173 | ADI-SPP-405-D | HSP40/Hdj2 (human), (recombinant) | 50 µg |
| 1174 | ADI-SPP-405-F | HSP40/Hdj2 (human), (recombinant) | 200 µg |
| 1175 | ADI-SPP-502-D | HSP70-A1 (mouse), (recombinant) | 50 µg |
| 1176 | ADI-SPP-502-F | HSP70-A1 (mouse), (recombinant) | 200 µg |
| 1177 | ADI-SPP-510-D | HSP25 (mouse), (recombinant) | 50 µg |
| 1178 | ADI-SPP-510-F | HSP25 (mouse), (recombinant) | 200 µg |
| 1179 | ADI-SPP-535-D | HSP47 (human), (recombinant) | 50 µg |
| 1180 | ADI-SPP-535-F | HSP47 (human), (recombinant) | 200 µg |
| 1181 | ADI-SPP-540-050 | HSP60 (human), (recombinant) | 50 µg |
| 1182 | ADI-SPP-540-200 | HSP60 (human), (recombinant) | 200 µg |
| 1183 | ADI-SPP-550-D | HO-2 (human), (recombinant) | 50 µg |
| 1184 | ADI-SPP-550-F | HO-2 (human), (recombinant) | 200 µg |
| 1185 | ADI-SPP-600-D | Calreticulin (human), (recombinant) (His-tag) | 50 µg |
| 1186 | ADI-SPP-600-F | Calreticulin (human), (recombinant) (His-tag) | 200 µg |
| 1187 | ADI-SPP-610-D | GroEL (<i>E. coli</i>), (recombinant) | 50 µg |
| 1188 | ADI-SPP-610-F | GroEL (<i>E. coli</i>), (recombinant) | 200 µg |
| 1189 | ADI-SPP-620-D | GroES (<i>E. coli</i>), (recombinant) | 50 µg |
| 1190 | ADI-SPP-620-F | GroES (<i>E. coli</i>), (recombinant) | 200 µg |
| 1191 | ADI-SPP-630-D | DnaK (<i>E. coli</i>), (recombinant) | 50 µg |
| 1192 | ADI-SPP-630-F | DnaK (<i>E. coli</i>), (recombinant) | 200 µg |
| 1193 | ADI-SPP-630-J | DnaK (<i>E. coli</i>), (recombinant) | 1 mg |
| 1194 | ADI-SPP-640-D | DnaJ (<i>E. coli</i>), (recombinant) (His-tag) | 50 µg |
| 1195 | ADI-SPP-640-F | DnaJ (<i>E. coli</i>), (recombinant) (His-tag) | 200 µg |
| 1196 | ADI-SPP-640-J | DnaJ (<i>E. coli</i>), (recombinant) (His-tag) | 1 mg |
| 1197 | ADI-SPP-650-D | GrpE (<i>E. coli</i>), (recombinant) | 50 µg |
| 1198 | ADI-SPP-650-F | GrpE (<i>E. coli</i>), (recombinant) | 200 µg |
| 1199 | ADI-SPP-670-D | p23 (human), (recombinant) | 50 µg |
| 1200 | ADI-SPP-670-F | p23 (human), (recombinant) | 200 µg |
| 1201 | ADI-SPP-715-D | HSP27 (human), (recombinant) | 50 µg |
| 1202 | ADI-SPP-715-F | HSP27 (human), (recombinant) | 200 µg |
| 1203 | ADI-SPP-716-D | HSP27 (phospho) (human), (recombinant) | 50 µg |
| 1204 | ADI-SPP-716-F | HSP27 (phospho) (human), (recombinant) | 200 µg |
| 1205 | ADI-SPP-721-050 | ERp72 (human), (recombinant) (His-tag) | 50 µg |
| 1206 | ADI-SPP-721-200 | ERp72 (human), (recombinant) (His-tag) | 200 µg |
| 1207 | ADI-SPP-732-D | HO-1 (human), (recombinant) | 50 µg |
| 1208 | ADI-SPP-732-F | HO-1 (human), (recombinant) | 200 µg |
| 1209 | ADI-SPP-741-D | HSP60 (mouse), (recombinant) | 50 µg |
| 1210 | ADI-SPP-741-F | HSP60 (mouse), (recombinant) | 200 µg |
| 1211 | ADI-SPP-742-D | HSP60 (rat), (recombinant) | 50 µg |
| 1212 | ADI-SPP-742-F | HSP60 (rat), (recombinant) | 200 µg |
| 1213 | ADI-SPP-751-D | HSC70/HSP73 (bovine), (recombinant) | 50 µg |
| 1214 | ADI-SPP-751-F | HSC70/HSP73 (bovine), (recombinant) | 200 µg |
| 1215 | ADI-SPP-752-D | HSC70/HSP73 (ATPase fragment) (bovine), (recombinant) | 50 µg |
| 1216 | ADI-SPP-752-F | HSC70/HSP73 (ATPase fragment) (bovine), (recombinant) | 200 µg |
| 1217 | ADI-SPP-758-D | HSP70/HSP72 (rat), (recombinant) | 50 µg |
| 1218 | ADI-SPP-758-F | HSP70/HSP72 (rat), (recombinant) | 200 µg |
| 1219 | ADI-SPP-761-E | HSC70/HSP73 (bovine), (recombinant) (biotin conjugate) | 100 µg |
| 1220 | ADI-SPP-762-E | HSP70B’ (human), (recombinant) | 100 µg |
| 1221 | ADI-SPP-763-D | HSP70/HSP72 (Chinook salmon), (recombinant) | 50 µg |
| 1222 | ADI-SPP-763-F | HSP70/HSP72 (Chinook salmon), (recombinant) | 200 µg |
| 1223 | ADI-SPP-765-D | Grp78/BiP (hamster), (recombinant) | 50 µg |
| 1224 | ADI-SPP-765-F | Grp78/BiP (hamster), (recombinant) | 200 µg |
| 1225 | ADI-SPP-766-D | Grp94 (canine), (recombinant) | 50 µg |
| 1226 | ADI-SPP-766-F | Grp94 (canine), (recombinant) | 200 µg |
| 1227 | ADI-SPP-767-E | Hip (rat), (recombinant) | 100 µg |
| 1228 | ADI-SPP-768-0050 | PERK (CT domain) (human), (recombinant) (His-tag) | 50 µg |
| 1229 | ADI-SPP-768-0200 | PERK (CT domain) (human), (recombinant) (His-tag) | 200 µg |
| 1230 | ADI-SPP-770-D | HSP90 (human), (native) | 50 µg |
| 1231 | ADI-SPP-770-F | HSP90 (human), (native) | 200 µg |
| 1232 | ADI-SPP-776-D | HSP90α (human), (recombinant) | 50 µg |
| 1233 | ADI-SPP-776-F | HSP90α (human), (recombinant) | 200 µg |
| 1234 | ADI-SPP-777-D | HSP90β (human), (recombinant) | 50 µg |
| 1235 | ADI-SPP-777-F | HSP90β (human), (recombinant) | 200 µg |
| 1236 | ADI-SPP-828-D | Grp75/Mortalin (human), (recombinant) | 50 µg |
| 1237 | ADI-SPP-828-F | Grp75/Mortalin (human), (recombinant) | 200 µg |
| 1238 | ADI-SPP-848-050 | TRAP1 (human), (recombinant) (His-tag) | 50 µg |
| 1239 | ADI-SPP-848-200 | TRAP1 (human), (recombinant) (His-tag) | 200 µg |
| 1240 | ADI-SPP-865-D | Calnexin (lumenal domain) (human), (recombinant) | 50 µg |
| 1241 | ADI-SPP-865-F | Calnexin (lumenal domain) (human), (recombinant) | 200 µg |
| 1242 | ADI-SPP-885-D | HSP71 (<em>M. tuberculosis</em>), (recombinant) | 50 µg |
| 1243 | ADI-SPP-885-F | HSP71 (<em>M. tuberculosis</em>), (recombinant) | 200 µg |
| 1244 | ADI-SPP-891-D | PDI (human), (recombinant) (His-tag) | 50 µg |
| 1245 | ADI-SPP-891-F | PDI (human), (recombinant) (His-tag) | 200 µg |
| 1246 | ADI-SPP-891-J | PDI (human), (recombinant) (His-tag) | 1 mg |
| 1247 | ADI-SPP-892-1 | Thioredoxin (<i>E. coli</i>), (recombinant) (His-tag) | 1 mg |
| 1248 | ADI-SPP-892-200 | Thioredoxin (<i>E. coli</i>), (recombinant) (His-tag) | 200 µg |
| 1249 | ADI-SPP-900-D | HSF1 (human), (recombinant) (His-tag) | 50 µg |
| 1250 | ADI-SPP-900-F | HSF1 (human), (recombinant) (His-tag) | 200 µg |
| 1251 | ADI-SPP-902-D | HSF1 (phosphorylated) (human), (recombinant) (His-tag) | 50 µg |
| 1252 | ADI-SPP-902-F | HSF1 (phosphorylated) (human), (recombinant) (His-tag) | 200 µg |
| 1253 | ADI-SPS-720-D | ERp72 polyclonal antibody | 50 µg |
| 1254 | ADI-SPS-720-F | ERp72 polyclonal antibody | 200 µg |
| 1255 | ADI-SPS-771-D | HSP90α polyclonal antibody | 50 µg |
| 1256 | ADI-SPS-771-F | HSP90α polyclonal antibody | 200 µg |
| 1257 | ADI-SPS-771PE-050 | HSP90α polyclonal antibody (PE conjugate) | 50 µg |
| 1258 | ADI-SPS-771PE-200 | HSP90α polyclonal antibody (PE conjugate) | 200 µg |
| 1259 | ADI-SPS-825-D | Grp75/Mortalin monoclonal antibody (30A5) | 50 µl |
| 1260 | ADI-SPS-825-F | Grp75/Mortalin monoclonal antibody (30A5) | 200 µl |
| 1261 | ADI-SPS-826-D | Grp75/Mortalin polyclonal antibody | 50 µg |
| 1262 | ADI-SPS-826-F | Grp75/Mortalin polyclonal antibody | 200 µg |
| 1263 | ADI-SPS-827-D | Grp75/Mortalin polyclonal antibody | 50 µg |
| 1264 | ADI-SPS-827-F | Grp75/Mortalin polyclonal antibody | 200 µg |
| 1265 | ADI-SPS-870-D | GroEL (<i>E. coli</i>) monoclonal antibody (9A1/2) | 50 µg |
| 1266 | ADI-SPS-870-F | GroEL (<i>E. coli</i>) monoclonal antibody (9A1/2) | 200 µg |
| 1267 | ADI-SPS-875-D | GroEL (<i>E. coli</i>) polyclonal antibody | 50 µg |
| 1268 | ADI-SPS-875-F | GroEL (<i>E. coli</i>) polyclonal antibody | 200 µg |
| 1269 | ADI-SRA-1000-D | Estrogen receptor monoclonal antibody (h-151) | 50 µg |
| 1270 | ADI-SRA-1000-F | Estrogen receptor monoclonal antibody (h-151) | 200 µg |
| 1271 | ADI-SRA-1010-D | Estrogen receptor α monoclonal antibody (C-542) | 50 µg |
| 1272 | ADI-SRA-1010-F | Estrogen receptor α monoclonal antibody (C-542) | 200 µg |
| 1273 | ADI-SRA-1400-D | FKBP59 monoclonal antibody (KN382/EC1) | 50 µg |
| 1274 | ADI-SRA-1400-F | FKBP59 monoclonal antibody (KN382/EC1) | 200 µg |
| 1275 | ADI-SRA-1500-D | HOP monoclonal antibody (DS14F5) | 50 µg |
| 1276 | ADI-SRA-1500-F | HOP monoclonal antibody (DS14F5) | 200 µg |
| 1277 | ADI-SRA-1800-D | UNC45a monoclonal antibody (AbS1) | 50 µg |
| 1278 | ADI-SRA-1800-F | UNC45a monoclonal antibody (AbS1) | 200 µg |
| 1279 | ADI-SRP-1510-D | HOP (human), (recombinant) | 50 µg |
| 1280 | ADI-SRP-1510-F | HOP (human), (recombinant) | 200 µg |
| 1281 | ADI-SYA-130-D | Synaptotagmin monoclonal antibody (ASV30) | 50 µg |
| 1282 | ADI-SYA-130-F | Synaptotagmin monoclonal antibody (ASV30) | 200 µg |
| 1283 | ADI-SYA-148-D | Synaptotagmin monoclonal antibody (ASV48) | 50 µg |
| 1284 | ADI-SYA-148-F | Synaptotagmin monoclonal antibody (ASV48) | 200 µg |
| 1285 | ADI-VAA-PT048-D | KDEL receptor monoclonal antibody (KR-10) | 50 µl |
| 1286 | ADI-VAA-PT048-F | KDEL receptor monoclonal antibody (KR-10) | 200 µl |
| 1287 | ADI-VAM-EN001-D | LAMP1 monoclonal antibody (Ly1C6) | 50 µg |
| 1288 | ADI-VAM-EN001-F | LAMP1 monoclonal antibody (Ly1C6) | 200 µg |
| 1289 | ADI-VAM-EN003-D | LAMP2 monoclonal antibody (GL2A7) | 50 µl |
| 1290 | ADI-VAM-EN003-F | LAMP2 monoclonal antibody (GL2A7) | 200 µl |
| 1291 | ADI-VAM-PS001-E | PSD-95 monoclonal antibody (7E3-1B8) | 100 µg |
| 1292 | ADI-VAM-PS002-E | PSD-95 monoclonal antibody (6G6-1C9) | 100 µg |
| 1293 | ADI-VAM-PS003-D | Bassoon monoclonal antibody (SAP7F407) | 50 µg |
| 1294 | ADI-VAM-PS003-F | Bassoon monoclonal antibody (SAP7F407) | 200 µg |
| 1295 | ADI-VAM-PS005-D | SAP97 monoclonal antibody (RPI 197.4) | 50 µg |
| 1296 | ADI-VAM-PS005-F | SAP97 monoclonal antibody (RPI 197.4) | 200 µg |
| 1297 | ADI-VAM-PS006-D | SAP102 monoclonal antibody (7D3 monoclonal antibody 119) | 50 µg |
| 1298 | ADI-VAM-PS006-F | SAP102 monoclonal antibody (7D3 monoclonal antibody 119) | 200 µg |
| 1299 | ADI-VAM-PT046-D | Membrin monoclonal antibody (4HAD6) | 50 µg |
| 1300 | ADI-VAM-PT046-F | Membrin monoclonal antibody (4HAD6) | 200 µg |
| 1301 | ADI-VAM-PT047-D | GS28 monoclonal antibody (HFD9) | 50 µg |
| 1302 | ADI-VAM-PT047-F | GS28 monoclonal antibody (HFD9) | 200 µg |
| 1303 | ADI-VAM-SV011-D | Synaptophysin monoclonal antibody (SP15) | 50 µl |
| 1304 | ADI-VAM-SV011-F | Synaptophysin monoclonal antibody (SP15) | 200 µl |
| 1305 | ADI-VAM-SV014-C | VAMP2 monoclonal antibody (SP10) | 25 µl |
| 1306 | ADI-VAM-SV014-E | VAMP2 monoclonal antibody (SP10) | 100 µl |
| 1307 | ADI-VAM-SV016-D | rSec8 monoclonal antibody (14G1) | 50 µg |
| 1308 | ADI-VAM-SV016-F | rSec8 monoclonal antibody (14G1) | 200 µg |
| 1309 | ADI-VAM-SV020-D | NSF monoclonal antibody (9G7-3) | 50 µg |
| 1310 | ADI-VAM-SV020-F | NSF monoclonal antibody (9G7-3) | 200 µg |
| 1311 | ADI-VAM-SV021-D | rSec6 monoclonal antibody (9H5) | 50 µg |
| 1312 | ADI-VAM-SV021-F | rSec6 monoclonal antibody (9H5) | 200 µg |
| 1313 | ADI-VAM-SV025-D | Syntaxin 6 monoclonal antibody (3D10) | 50 µg |
| 1314 | ADI-VAM-SV025-F | Syntaxin 6 monoclonal antibody (3D10) | 200 µg |
| 1315 | ADI-VAM-SV026-E | Syntaxin 13 monoclonal antibody (15G2) | 100 µg |
| 1316 | ADI-VAM-SV041-E | Dynamin monoclonal antibody (D5) | 100 µg |
| 1317 | ADI-VAP-EN004-D | Transferrin polyclonal antibody | 50 µg |
| 1318 | ADI-VAP-EN004-F | Transferrin polyclonal antibody | 200 µg |
| 1319 | ADI-VAP-PT034-E | Glucosidase II α polyclonal antibody | 100 µl |
| 1320 | ADI-VAP-PT049-C | Membrin polyclonal antibody | 25 µg |
| 1321 | ADI-VAP-PT068-E | UGGT polyclonal antibody | 100 µl |
| 1322 | ADI-VAP-SV002-E | SNAP-25 polyclonal antibody | 100 µg |
| 1323 | ADI-VAP-SV003-E | CSP polyclonal antibody | 100 µg |
| 1324 | ADI-VAP-SV015-E | [pSer<sup>9</sup>]Synapsin I polyclonal antibody | 100 µl |
| 1325 | ADI-VAP-SV060-E | Synapsin I polyclonal antibody | 100 µg |
| 1326 | ADI-VAP-SV064-E | Syntaxin 1A polyclonal antibody | 100 µg |
| 1327 | ADI-VAP-SV065-E | Syntaxin 2 polyclonal antibody | 100 µg |
| 1328 | ADI-VAS-SV006-D | VAMP2 polyclonal antibody | 50 µg |
| 1329 | ADI-VAS-SV006-F | VAMP2 polyclonal antibody | 200 µg |
| 1330 | ADI-VAS-SV008-D | Synaptotagmin I polyclonal antibody | 50 µg |
| 1331 | ADI-VAS-SV008-F | Synaptotagmin I polyclonal antibody | 200 µg |
| 1332 | ADI-VAS-SV061-E | Synapsin II polyclonal antibody | 100 µg |
| 1333 | AG-45A-0006EK-KI01 | Nampt (Visfatin/PBEF) (human) Intracellular ELISA Kit | 96 wells |
| 1334 | AG-45A-0007EK-KI01 | Nampt (Visfatin/PBEF) (mouse/rat) Dual ELISA Kit | 96 wells |
| 1335 | ALX-101-004-G025 | L-Arginine | 25 g |
| 1336 | ALX-101-012-G010 | L-Cysteine . hydrochloride | 10 g |
| 1337 | ALX-101-037-G005 | D-Ornithine . hydrochloride | 5 g |
| 1338 | ALX-101-057-G010 | L-Histidine . hydrochloride . monohydrate | 10 g |
| 1339 | ALX-101-058-G001 | D-Histidine . hydrochloride . monohydrate | 1 g |
| 1340 | ALX-105-003-G005 | L-NAME . hydrochloride | 5 g |
| 1341 | ALX-105-003-G025 | L-NAME . hydrochloride | 25 g |
| 1342 | ALX-105-005-G005 | N-Acetyl-L-cysteine | 5 g |
| 1343 | ALX-105-009-M050 | N-Methyl-D-aspartic acid | 50 mg |
| 1344 | ALX-105-010-M050 | N-Methyl-L-aspartic acid | 50 mg |
| 1345 | ALX-105-011-M500 | S-Trityl-L-cysteine | 500 mg |
| 1346 | ALX-106-001-G001 | L-NMMA . monoacetate | 1 g |
| 1347 | ALX-106-001-M025 | L-NMMA . monoacetate | 25 mg |
| 1348 | ALX-106-001-M100 | L-NMMA . monoacetate | 100 mg |
| 1349 | ALX-106-002-M025 | D-NMMA . monoacetate | 25 mg |
| 1350 | ALX-106-002-M100 | D-NMMA . monoacetate | 100 mg |
| 1351 | ALX-106-004-M005 | N<sup>G</sup>-Hydroxy-L-arginine . monoacetate | 5 mg |
| 1352 | ALX-106-004-M025 | N<sup>G</sup>-Hydroxy-L-arginine . monoacetate | 25 mg |
| 1353 | ALX-106-006-M005 | N<sup>G</sup>, N<sup>G</sup>-Dimethyl-L-arginine . dihydrochloride | 5 mg |
| 1354 | ALX-106-006-M025 | N<sup>G</sup>, N<sup>G</sup>-Dimethyl-L-arginine . dihydrochloride | 25 mg |
| 1355 | ALX-106-007-M025 | N<sup>G</sup>, N'<sup>G</sup>-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p’-sulfonate) | 25 mg |
| 1356 | ALX-106-008-M025 | N<sup>G</sup>, N'<sup>G</sup>-Dimethyl-L-arginine . dihydrochloride | 25 mg |
| 1357 | ALX-106-012-M010 | S-Methyl-L-thiocitrulline . dihydrochloride | 10 mg |
| 1358 | ALX-106-012-M050 | S-Methyl-L-thiocitrulline . dihydrochloride | 50 mg |
| 1359 | ALX-106-013-M010 | L-Thiocitrulline . dihydrochloride | 10 mg |
| 1360 | ALX-106-013-M050 | L-Thiocitrulline . dihydrochloride | 50 mg |
| 1361 | ALX-106-014-M005 | N<sup>G</sup>-Amino-L-arginine . hydrochloride | 5 mg |
| 1362 | ALX-106-023-M500 | 5-Hydroxy-L-tryptophan | 500 mg |
| 1363 | ALX-106-024-G001 | O-Phospho-L-serine | 1 g |
| 1364 | ALX-106-031-M050 | p-Chloro-L-phenylalanine | 50 mg |
| 1365 | ALX-106-037-M100 | L-Cycloserine | 100 mg |
| 1366 | ALX-106-040-M050 | 1-Methyl-L-tryptophan | 50 mg |
| 1367 | ALX-106-041-M050 | 1-Methyl-D-tryptophan | 50 mg |
| 1368 | ALX-106-042-G025 | L-Theanine | 25 g |
| 1369 | ALX-121-002-G500 | TBTU | 500 g |
| 1370 | ALX-121-003-G100 | HBTU | 100 g |
| 1371 | ALX-121-003-G250 | HBTU | 250 g |
| 1372 | ALX-151-002-P001 | β-Amyloid (1-42) | 1 mg* |
| 1373 | ALX-151-002-PC05 | β-Amyloid (1-42) | 0.5 mg* |
| 1374 | ALX-151-003-P001 | β-Amyloid (1-40) | 1 mg* |
| 1375 | ALX-151-003-PC05 | β-Amyloid (1-40) | 0.5 mg* |
| 1376 | ALX-151-005-P001 | β-Amyloid (1-28) | 1 mg* |
| 1377 | ALX-151-005-PC05 | β-Amyloid (1-28) | 0.5 mg* |
| 1378 | ALX-151-008-P001 | β-Amyloid (25-35) | 1 mg* |
| 1379 | ALX-151-008-P005 | β-Amyloid (25-35) | 5 mg* |
| 1380 | ALX-151-011-P001 | β-Amyloid/A4 protein precursor (328-332) | 1 mg* |
| 1381 | ALX-151-011-P005 | β-Amyloid/A4 protein precursor (328-332) | 5 mg* |
| 1382 | ALX-151-013-MC05 | Apamin | 0.5 mg |
| 1383 | ALX-151-016-M001 | cAMP-dependent protein kinase inhibitor (5-22) amide | 1 mg |
| 1384 | ALX-151-019-M001 | cAMP-dependent protein kinase substrate | 1 mg |
| 1385 | ALX-151-019-MC05 | cAMP-dependent protein kinase substrate | 0.5 mg |
| 1386 | ALX-151-020-M010 | N-Acetyl-Asp-Glu-OH | 10 mg |
| 1387 | ALX-151-020-M050 | N-Acetyl-Asp-Glu-OH | 50 mg |
| 1388 | ALX-151-021-M001 | H-Arg-Gly-Tyr-Ser-Leu-Gly-OH | 1 mg |
| 1389 | ALX-151-024-M001 | H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH | 1 mg |
| 1390 | ALX-151-027-M001 | N-Acetyl-Asp-Tyr(PO<sub>3</sub>H<sub>2</sub>)-Val-Pro-Met-Leu-NH<sub>2</sub> | 1 mg |
| 1391 | ALX-151-029-M001 | Autocamtide-2-related inhibitory peptide | 1 mg |
| 1392 | ALX-151-029-M005 | Autocamtide-2-related inhibitory peptide | 5 mg |
| 1393 | ALX-151-030-MC05 | Autocamtide-2-related inhibitory peptide (myristoylated) | 0.5 mg |
| 1394 | ALX-151-035-M001 | Ac-muramyl-Ala-D-Glu-amide | 1 mg |
| 1395 | ALX-151-035-M005 | Ac-muramyl-Ala-D-Glu-amide | 5 mg |
| 1396 | ALX-151-036-M001 | Ac-muramyl-D-Ala-D-Glu-amide | 1 mg |
| 1397 | ALX-151-036-M005 | Ac-muramyl-D-Ala-D-Glu-amide | 5 mg |
| 1398 | ALX-151-037-M005 | Angiotensin I | 5 mg |
| 1399 | ALX-151-039-M005 | Angiotensin II | 5 mg |
| 1400 | ALX-151-039-M025 | Angiotensin II | 25 mg |
| 1401 | ALX-151-041-M005 | Angiotensin I/II (1-7) | 5 mg |
| 1402 | ALX-151-042-M005 | Angiotensin IV | 5 mg |
| 1403 | ALX-151-043-M005 | Angiotensin III | 5 mg |
| 1404 | ALX-151-045-C100 | Blocking peptide for Adiponectin receptor 1 pAb (Prod. No. ALX-210-645) | 100 µg |
| 1405 | ALX-152-001-P001 | Big Endothelin-1 (human) (1-38) | 1 mg* |
| 1406 | ALX-152-001-PC01 | Big Endothelin-1 (human) (1-38) | 0.1 mg* |
| 1407 | ALX-152-001-PC05 | Big Endothelin-1 (human) (1-38) | 0.5 mg* |
| 1408 | ALX-152-003-PC01 | Big Endothelin-1 (rat) (1-39) | 0.1 mg* |
| 1409 | ALX-152-003-PC05 | Big Endothelin-1 (rat) (1-39) | 0.5 mg* |
| 1410 | ALX-152-006-M005 | Bradykinin | 5 mg |
| 1411 | ALX-152-006-M025 | Bradykinin | 25 mg |
| 1412 | ALX-152-028-1 | Bax (human) (58-75), (cell permeable) | 1 Vial |
| 1413 | ALX-153-003-M005 | Casein kinase II substrate | 5 mg |
| 1414 | ALX-153-012-M001 | Cyclin-dependent kinase 2 inhibitor | 1 mg |
| 1415 | ALX-153-055-G001 | Carnosine | 1 g |
| 1416 | ALX-153-064-M001 | Caveolin-1 scaffolding domain peptide | 1 mg |
| 1417 | ALX-153-064-M005 | Caveolin-1 scaffolding domain peptide | 5 mg |
| 1418 | ALX-153-066-C100 | Blocking peptide for CCR3 (mouse) pAb (Prod. No. ALX-210-641) | 100 µg |
| 1419 | ALX-155-001-P001 | Endothelin-1 (human, mouse, rat, pig, bovine, dog) | 1 mg* |
| 1420 | ALX-155-001-PC01 | Endothelin-1 (human, mouse, rat, pig, bovine, dog) | 0.1 mg* |
| 1421 | ALX-155-001-PC05 | Endothelin-1 (human, mouse, rat, pig, bovine, dog) | 0.5 mg* |
| 1422 | ALX-155-002-PC01 | Endothelin-2 (human, pig, dog) | 0.1 mg* |
| 1423 | ALX-155-003-PC01 | Endothelin-3 (human, rat, pig) | 0.1 mg* |
| 1424 | ALX-155-003-PC05 | Endothelin-3 (human, rat, pig) | 0.5 mg* |
| 1425 | ALX-155-004-P001 | ET<sub>A</sub> receptor antagonist [BQ-123] . sodium salt | 1 mg* |
| 1426 | ALX-155-004-P005 | ET<sub>A</sub> receptor antagonist [BQ-123] . sodium salt | 5 mg* |
| 1427 | ALX-155-007-P001 | ET<sub>B</sub> receptor antagonist [IRL-1038] | 1 mg* |
| 1428 | ALX-155-007-PC05 | ET<sub>B</sub> receptor antagonist [IRL-1038] | 0.5 mg* |
| 1429 | ALX-155-008-P001 | ET receptor antagonist [PD 142,893] | 1 mg* |
| 1430 | ALX-155-008-PC05 | ET receptor antagonist [PD 142,893] | 0.5 mg* |
| 1431 | ALX-155-011-P001 | ET<sub>A</sub> receptor antagonist [BQ-610] | 1 mg* |
| 1432 | ALX-155-012-P001 | ET<sub>A</sub> receptor antagonist [JKC-301] | 1 mg* |
| 1433 | ALX-155-012-PC05 | ET<sub>A</sub> receptor antagonist [JKC-301] | 0.5 mg* |
| 1434 | ALX-155-016-P001 | ET receptor antagonist [PD 145,065] | 1 mg* |
| 1435 | ALX-155-016-PC05 | ET receptor antagonist [PD 145,065] | 0.5 mg* |
| 1436 | ALX-155-017-P001 | ET<sub>A</sub> receptor antagonist [FR 139317] | 1 mg* |
| 1437 | ALX-155-017-PC05 | ET<sub>A</sub> receptor antagonist [FR 139317] | 0.5 mg* |
| 1438 | ALX-155-018-MC05 | ET<sub>B</sub> receptor antagonist [RES-701-1] | 0.5 mg |
| 1439 | ALX-155-020-M001 | ET<sub>B</sub> receptor antagonist . sodium salt | 1 mg |
| 1440 | ALX-155-020-MC05 | ET<sub>B</sub> receptor antagonist . sodium salt | 0.5 mg |
| 1441 | ALX-155-022-M001 | EGF receptor (human) (651-658) (myristoylated) | 1 mg |
| 1442 | ALX-155-022-M005 | EGF receptor (human) (651-658) (myristoylated) | 5 mg |
| 1443 | ALX-155-023-M001 | EGF receptor (human) (652-657) | 1 mg |
| 1444 | ALX-155-023-M005 | EGF receptor (human) (652-657) | 5 mg |
| 1445 | ALX-155-037-M001 | Extracellular death factor | 1 mg |
| 1446 | ALX-157-001-G001 | L-Glutathione (oxidized form) | 1 g |
| 1447 | ALX-157-001-G005 | L-Glutathione (oxidized form) | 5 g |
| 1448 | ALX-157-001-M250 | L-Glutathione (oxidized form) | 250 mg |
| 1449 | ALX-157-002-G005 | L-Glutathione (reduced form) | 5 g |
| 1450 | ALX-157-002-G025 | L-Glutathione (reduced form) | 25 g |
| 1451 | ALX-157-003-P001 | Galanin (human) | 1 mg* |
| 1452 | ALX-157-010-MC01 | Guanylin (human) | 0.1 mg |
| 1453 | ALX-157-011-MC01 | Guanylin (rat, mouse) | 0.1 mg |
| 1454 | ALX-157-021-M001 | Ghrelin (human) | 1 mg |
| 1455 | ALX-157-021-MC05 | Ghrelin (human) | 0.5 mg |
| 1456 | ALX-157-022-M001 | Ghrelin (rat) | 1 mg |
| 1457 | ALX-157-022-MC05 | Ghrelin (rat) | 0.5 mg |
| 1458 | ALX-158-003-M001 | Histone H2B (29-35) | 1 mg |
| 1459 | ALX-158-011-M001 | Humanin (human) | 1 mg |
| 1460 | ALX-158-011-MC05 | Humanin (human) | 0.5 mg |
| 1461 | ALX-162-004-M001 | MARCKS protein (bovine brain) (151-175) | 1 mg |
| 1462 | ALX-162-004-MC05 | MARCKS protein (bovine brain) (151-175) | 0.5 mg |
| 1463 | ALX-162-005-M001 | MARCKS protein (bovine brain) (159-165) amide | 1 mg |
| 1464 | ALX-162-006-M001 | Melittin (natural) | 1 mg |
| 1465 | ALX-162-006-M005 | Melittin (natural) | 5 mg |
| 1466 | ALX-162-007-M001 | Melittin (synthetic) | 1 mg |
| 1467 | ALX-162-007-MC05 | Melittin (synthetic) | 0.5 mg |
| 1468 | ALX-162-009-M001 | Myelin basic protein (bovine) (4-14) | 1 mg |
| 1469 | ALX-162-009-M005 | Myelin basic protein (bovine) (4-14) | 5 mg |
| 1470 | ALX-162-011-M001 | Myosin light chain kinase (11-19) amide | 1 mg |
| 1471 | ALX-162-013-M001 | Myosin light chain kinase substrate | 1 mg |
| 1472 | ALX-162-017-M001 | N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH | 1 mg |
| 1473 | ALX-162-017-M005 | N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH | 5 mg |
| 1474 | ALX-162-027-C050 | MALP-2 | 50 µg |
| 1475 | ALX-162-030-M001 | Myelin oligodendrocyte glycoprotein (mouse, rat) (35-55) | 1 mg |
| 1476 | ALX-162-030-MC05 | Myelin oligodendrocyte glycoprotein (mouse, rat) (35-55) | 0.5 mg |
| 1477 | ALX-162-031-M001 | Myelin proteolipid protein (human, bovine, dog, mouse, rat) (139-151) | 1 mg |
| 1478 | ALX-162-034-C500 | MALP-2 (BULK) | 500 µg |
| 1479 | ALX-163-001-P001 | Nociceptin | 1 mg* |
| 1480 | ALX-163-001-P005 | Nociceptin | 5 mg* |
| 1481 | ALX-163-002-P001 | Neurotensin | 1 mg* |
| 1482 | ALX-163-002-P005 | Neurotensin | 5 mg* |
| 1483 | ALX-163-003-P001 | NPY (human) | 1 mg* |
| 1484 | ALX-163-003-PC05 | NPY (human) | 0.5 mg* |
| 1485 | ALX-163-011-1 | NBD peptide / NF-κB blocker (cell permeable) | 1 Vial |
| 1486 | ALX-164-001-C100 | Orexin A (human, bovine, rat, mouse) | 100 µg |
| 1487 | ALX-164-001-M001 | Orexin A (human, bovine, rat, mouse) | 1 mg |
| 1488 | ALX-164-004-M001 | Obestatin (human) | 1 mg |
| 1489 | ALX-164-005-M001 | Obestatin (mouse, rat) | 1 mg |
| 1490 | ALX-164-005-M005 | Obestatin (mouse, rat) | 5 mg |
| 1491 | ALX-165-004-M001 | pp60<sup>v-src</sup> (137-157) | 1 mg |
| 1492 | ALX-165-007-M001 | Phospholipase A<sub>2</sub> activating peptide | 1 mg |
| 1493 | ALX-165-007-MC01 | Phospholipase A<sub>2</sub> activating peptide | 0.1 mg |
| 1494 | ALX-165-009-M001 | Protein kinase C (19-31) | 1 mg |
| 1495 | ALX-165-009-M005 | Protein kinase C (19-31) | 5 mg |
| 1496 | ALX-165-017-M001 | [Ser<sup>25</sup>]-Protein kinase C (19-31) | 1 mg |
| 1497 | ALX-165-017-M005 | [Ser<sup>25</sup>]-Protein kinase C (19-31) | 5 mg |
| 1498 | ALX-165-022-M001 | [pTyr<sup>527</sup>]pp60<sup>c-src</sup> (521-533) | 1 mg |
| 1499 | ALX-165-022-MC05 | [pTyr<sup>527</sup>]pp60<sup>c-src</sup> (521-533) | 0.5 mg |
| 1500 | ALX-165-024-M001 | PKI-tide | 1 mg |
| 1501 | ALX-165-024-M005 | PKI-tide | 5 mg |
| 1502 | ALX-165-066-M002 | Pam<sub>3</sub>Cys-Ser-(Lys)<sub>4</sub> . trihydrochloride | 2 mg |
| 1503 | ALX-165-069-M001 | Pam<sub>3</sub>Cys-Ser-(Lys)<sub>4</sub> (Aca-Aca-Biotin) . 2 trifluoroacetate | 1 mg |
| 1504 | ALX-165-071-M001 | PHC-SKKKK . 3 TFA | 1 mg |
| 1505 | ALX-166-001-M001 | Ras inhibitory peptide | 1 mg |
| 1506 | ALX-166-001-M005 | Ras inhibitory peptide | 5 mg |
| 1507 | ALX-167-003-M001 | Substance P | 1 mg |
| 1508 | ALX-167-003-M005 | Substance P | 5 mg |
| 1509 | ALX-168-009F-R050 | L-TAT control peptide (FITC conjugate) | 50 µl |
| 1510 | ALX-168-009-R050 | L-TAT control peptide | 50 µl |
| 1511 | ALX-168-010F-R025 | D-TAT control peptide (FITC conjugate) | 25 µl |
| 1512 | ALX-168-010-R025 | D-TAT control peptide | 25 µl |
| 1513 | ALX-170-005-C050 | Blocking peptide for TRPV1 (human) pAb (Prod. No. BML-SA556) | 50 µg |
| 1514 | ALX-190-001-M050 | H-Trp-Glu-OH | 50 mg |
| 1515 | ALX-200-089-M001 | Ceruloplasmin (human plasma) | 1 mg |
| 1516 | ALX-200-418-C005 | MMP-1 proenzyme (human fibroblasts) | 5 µg |
| 1517 | ALX-200-419-C005 | MMP-2 proenzyme (human fibroblasts) | 5 µg |
| 1518 | ALX-200-420-C005 | MMP-2/TIMP-2 proenzyme complex (human fibroblasts) | 5 µg |
| 1519 | ALX-200-421-C005 | MMP-8 proenzyme (human neutrophils) | 5 µg |
| 1520 | ALX-200-422-C005 | MMP-9 proenzyme (human neutrophils), monomer | 5 µg |
| 1521 | ALX-200-423-C005 | MMP-9 (human neutrophils), dimer | 5 µg |
| 1522 | ALX-200-426-C005 | TIMP-1 (human neutrophils) | 5 µg |
| 1523 | ALX-200-430-C010 | MMP-9 proenzyme (human), monomer | 10 µg |
| 1524 | ALX-200-600A-5025 | Myeloperoxidase (human leukocytes) | 5 x 25 µg |
| 1525 | ALX-200-600A-U025 | Myeloperoxidase (human leukocytes) | 25 µg |
| 1526 | ALX-200-602-C010 | Granzyme B (human lymphocytes) | 10 µg |
| 1527 | ALX-200-604-C001 | Perforin (human) | 1 µg |
| 1528 | ALX-200-605-C010 | Granzyme A (human) | 10 µg |
| 1529 | ALX-200-606-M001 | Myelin basic protein (human brain), (high purity) | 1 mg |
| 1530 | ALX-201-002-U050 | Furin convertase (human), (recombinant) | 50 U |
| 1531 | ALX-201-006-M001 | N-Acetyl-eglin C, (recombinant) | 1 mg |
| 1532 | ALX-201-006-MC01 | N-Acetyl-eglin C, (recombinant) | 0.1 mg |
| 1533 | ALX-201-006-MC05 | N-Acetyl-eglin C, (recombinant) | 0.5 mg |
| 1534 | ALX-201-023-C100 | Cyclophilin A (human), (recombinant) | 100 µg |
| 1535 | ALX-201-034-M001 | Leptin (human), (recombinant) | 1 mg |
| 1536 | ALX-201-035-M001 | Leptin (mouse), (recombinant) | 1 mg |
| 1537 | ALX-201-040-C005 | Caspase-7 (human), (recombinant) (active) | 5 µg |
| 1538 | ALX-201-042-C005 | MMP-3 (catalytic domain) (human), (recombinant) | 5 µg |
| 1539 | ALX-201-044-C250 | SUMO-1 (human) (1-101), (recombinant) | 250 µg |
| 1540 | ALX-201-045-C500 | SUMO-1 (human) (1-97), (recombinant) | 500 µg |
| 1541 | ALX-201-046-C050 | Ubc9 (human), (recombinant) | 50 µg |
| 1542 | ALX-201-047-U025 | Caspase-9 (human), (recombinant) (active) | 25 U |
| 1543 | ALX-201-047-U100 | Caspase-9 (human), (recombinant) (active) | 100 U |
| 1544 | ALX-201-055-C010 | Phosphoinositide 3-kinase p110γ (human), (recombinant) | 10 µg |
| 1545 | ALX-201-056-U025 | Caspase-1 (human), (recombinant) (active) | 25 U |
| 1546 | ALX-201-056-U100 | Caspase-1 (human), (recombinant) (active) | 100 U |
| 1547 | ALX-201-057-U025 | Caspase-2 (human), (recombinant) (active) | 25 U |
| 1548 | ALX-201-057-U100 | Caspase-2 (human), (recombinant) (active) | 100 U |
| 1549 | ALX-201-059-U025 | Caspase-3 (human), (recombinant) (active) | 25 U |
| 1550 | ALX-201-059-U100 | Caspase-3 (human), (recombinant) (active) | 100 U |
| 1551 | ALX-201-060-U025 | Caspase-6 (human), (recombinant) (active) | 25 U |
| 1552 | ALX-201-060-U100 | Caspase-6 (human), (recombinant) (active) | 100 U |
| 1553 | ALX-201-061-U025 | Caspase-7 (human), (recombinant) (active) | 25 U |
| 1554 | ALX-201-061-U100 | Caspase-7 (human), (recombinant) (active) | 100 U |
| 1555 | ALX-201-062-U025 | Caspase-8 (human), (recombinant) (active) | 25 U |
| 1556 | ALX-201-062-U100 | Caspase-8 (human), (recombinant) (active) | 100 U |
| 1557 | ALX-201-063-C020 | PARP-1 (human), (recombinant) (high purity) | 20 µg |
| 1558 | ALX-201-064-C020 | PARP-2 (mouse), (recombinant) (high purity) | 20 µg |
| 1559 | ALX-201-073-3020 | <em>Killer</em>TRAIL™ Protein (soluble) (human), (recombinant) | 3 x 20 µg |
| 1560 | ALX-201-073-C020 | <em>Killer</em>TRAIL™ Protein (soluble) (human), (recombinant) | 20 µg |
| 1561 | ALX-201-078-C005 | Caspase-3 (rat), (recombinant) | 5 µg |
| 1562 | ALX-201-081-C020 | Arginase I (human), (recombinant) | 20 µg |
| 1563 | ALX-201-086-C250 | SUMO-3 (human) (1-103), (recombinant) | 250 µg |
| 1564 | ALX-201-087-C500 | SUMO-3 (human) (1-92), (recombinant) | 500 µg |
| 1565 | ALX-201-088-C250 | SUMO-2 (human) (1-95), (recombinant) | 250 µg |
| 1566 | ALX-201-089-C500 | SUMO-2 (human) (1-93), (recombinant) | 500 µg |
| 1567 | ALX-201-093-U025 | Caspase-4 (human), (recombinant) (active) | 25 U |
| 1568 | ALX-201-093-U100 | Caspase-4 (human), (recombinant) (active) | 100 U |
| 1569 | ALX-201-095-C010 | MMP-2 proenzyme (human), (recombinant) | 10 µg |
| 1570 | ALX-201-098-C010 | MMP-14 (catalytic domain) (human), (recombinant) | 10 µg |
| 1571 | ALX-201-099-C010 | MMP-14 prodomain (catalytic domain) (human), (recombinant) (His-tag) | 10 µg |
| 1572 | ALX-201-100-C010 | MMP-14 proenzyme (soluble) (human), (recombinant) (His-tag) | 10 µg |
| 1573 | ALX-201-105-C010 | MMP-24 (catalytic domain) (human), (recombinant) (His-tag) | 10 µg |
| 1574 | ALX-201-115-3010 | SUPERKILLERTRAIL<sup>®</sup> Protein (soluble) (human), (recombinant) | 3 x 10 µg |
| 1575 | ALX-201-115-C010 | SUPERKILLERTRAIL<sup>®</sup> Protein (soluble) (human), (recombinant) | 10 µg |
| 1576 | ALX-201-116-C100 | Annexin V (human), (recombinant) (GST-tag) | 100 µg |
| 1577 | ALX-201-117-C010 | Granzyme K (human), (recombinant) | 10 µg |
| 1578 | ALX-201-118-C010 | Granzyme A (human), (recombinant) | 10 µg |
| 1579 | ALX-201-119-C005 | Phosphoinositide 3-kinase p110α/p85 (bovine), (recombinant) | 5 µg |
| 1580 | ALX-201-123-C500 | <em>Killer</em>TRAIL™ Protein (soluble) (human), (recombinant) (BULK) | 500 µg |
| 1581 | ALX-201-124-C010 | PTX3 (human), (recombinant) | 10 µg |
| 1582 | ALX-201-125-C050 | Prothymosin α (human) (1-99), (recombinant) | 50 µg |
| 1583 | ALX-201-128-1 | CD26 (human), (recombinant) | 1 Vial |
| 1584 | ALX-201-131-C010 | LBP (human), (recombinant) (His-tag) | 10 µg |
| 1585 | ALX-201-132-C010 | LBP (mouse), (recombinant) (His-tag) | 10 µg |
| 1586 | ALX-201-133-C010 | CD14 (human), (recombinant) | 10 µg |
| 1587 | ALX-201-134-C010 | CD14 (mouse), (recombinant) (His-tag) | 10 µg |
| 1588 | ALX-201-136-C005 | Caspase-9 (human), (recombinant) (active) | 5 µg |
| 1589 | ALX-201-138-C025 | HSP90 (yeast), (recombinant) (His-tag) | 25 µg |
| 1590 | ALX-201-138-C100 | HSP90 (yeast), (recombinant) (His-tag) | 100 µg |
| 1591 | ALX-201-141-C025 | GroEL (<i>E. coli</i>), (recombinant) | 25 µg |
| 1592 | ALX-201-142-C025 | GroES (<i>E. coli</i>), (recombinant) | 25 µg |
| 1593 | ALX-201-143-C025 | DnaK (<i>E. coli</i>), (recombinant) | 25 µg |
| 1594 | ALX-201-144-C025 | DnaJ (<i>E. coli</i>), (recombinant) | 25 µg |
| 1595 | ALX-201-145-C025 | GrpE (<i>E. coli</i>), (recombinant) | 25 µg |
| 1596 | ALX-201-147-C025 | HSP90β (human), (recombinant) | 25 µg |
| 1597 | ALX-201-153-C025 | DsbA (<i>E. coli</i>), (recombinant) | 25 µg |
| 1598 | ALX-201-163-C020 | Caspase-8 (mouse), (recombinant) (active) | 20 µg |
| 1599 | ALX-201-165-C050 | Procaspase-9 (mouse), (recombinant) | 50 µg |
| 1600 | ALX-201-170-C020 | PARP-3 (human), (recombinant) (high purity) | 20 µg |
| 1601 | ALX-201-171-C050 | NEDP1 (human), (recombinant) | 50 µg |
| 1602 | ALX-201-177-C010 | Guanylyl cyclase α<sub>1</sub>β<sub>1</sub> (soluble) (human), (recombinant) (His-tag) (purified) | 10 µg |
| 1603 | ALX-201-178-C100 | SET7/9 (human), (recombinant) | 100 µg |
| 1604 | ALX-201-180-R050 | Guanylyl cyclase α1β1 (soluble) (human), (recombinant) (His-tag) (enriched) | 50 µl |
| 1605 | ALX-201-184-C100 | LAIR-1 (human) (22-125), (recombinant) | 100 µg |
| 1606 | ALX-201-197-C100 | γ-Synuclein (human), (recombinant) | 100 µg |
| 1607 | ALX-201-201-C100 | Human growth hormone, (recombinant) | 100 µg |
| 1608 | ALX-201-204-C010 | pro-Bone morphogenetic protein 2 (human), (recombinant) | 10 µg |
| 1609 | ALX-201-205-C010 | Bone morphogenetic protein 2 (human), (recombinant) | 10 µg |
| 1610 | ALX-201-212-C025 | HDJ2 (human), (recombinant) | 25 µg |
| 1611 | ALX-201-216-C025 | Hip (human), (recombinant) | 25 µg |
| 1612 | ALX-201-217-C100 | DnaK (E. coli) (1-638), (recombinant) | 100 µg |
| 1613 | ALX-201-221-C100 | Pin1 (human), (recombinant) | 100 µg |
| 1614 | ALX-201-231-M001 | Leptin (rat), (recombinant) | 1 mg |
| 1615 | ALX-201-232-C020 | PARP-1 (catalytic domain) (human), (recombinant) (His-tag) | 20 µg |
| 1616 | ALX-201-238-C100 | NMNAT3 (human), (recombinant) (His-tag) | 100 µg |
| 1617 | ALX-201-239-C010 | Procathepsin K (human), (recombinant) | 10 µg |
| 1618 | ALX-201-240-C100 | Elafin (human), (recombinant) | 100 µg |
| 1619 | ALX-201-242-L001 | LIF (mouse), (recombinant) | 1 ml |
| 1620 | ALX-201-246-U250 | Matriptase (human), (recombinant) (His-tag) | 250 U |
| 1621 | ALX-201-250-C010 | PARP-1 (human), (recombinant) (high purity) (His-tag) | 10 µg |
| 1622 | ALX-201-251-C010 | PARP-2 (mouse), (recombinant) (high purity) (His-tag) | 10 µg |
| 1623 | ALX-201-252-C010 | PARP-3 (human), (recombinant) (high purity) (His-tag) | 10 µg |
| 1624 | ALX-201-255-C020 | PARP-1 (BRCT domain) (human), (recombinant) (His-tag) | 20 µg |
| 1625 | ALX-201-261-C010 | Nitric oxide synthase (neuronal) (human), (recombinant) (purified) | 10 µg |
| 1626 | ALX-201-262-C050 | Saposin C (human), (recombinant) | 50 µg |
| 1627 | ALX-201-264-C250 | Nitric oxide synthase (neuronal) (oxygenase domain) (human), (recombinant) (purified) | 250 µg |
| 1628 | ALX-201-265-C100 | α-Synuclein (human), (recombinant) | 100 µg |
| 1629 | ALX-201-268-C100 | DsbC (<i>E. coli</i>), (recombinant) | 100 µg |
| 1630 | ALX-201-274-C100 | HSP40 (human), (recombinant) (His-tag) | 100 µg |
| 1631 | ALX-201-275-C100 | Activator of HSP90 ATPase 1 (human), (recombinant) | 100 µg |
| 1632 | ALX-201-279-C002 | CREB binding protein (mouse), (recombinant) (His-tag) | 2 µg |
| 1633 | ALX-201-280-C002 | GCN5 (human), (recombinant) (His-tag) | 2 µg |
| 1634 | ALX-201-283-C002 | CARM1 (human), (recombinant) (His-tag) | 2 µg |
| 1635 | ALX-201-284-C002 | NF-κB (p65) (human), (recombinant) (His-tag) | 2 µg |
| 1636 | ALX-201-285-C002 | NF-κB (p50) (human), (recombinant) (His-tag) | 2 µg |
| 1637 | ALX-201-286-C010 | Minor vault p193 protein (human), (recombinant) (His-tag) | 10 µg |
| 1638 | ALX-201-290-C010 | ARH1 (human), (recombinant) (His-tag) | 10 µg |
| 1639 | ALX-201-292-C010 | ARH3 (human), (recombinant) (His-tag) | 10 µg |
| 1640 | ALX-201-310-C050 | Resistin (mouse), (recombinant) | 50 µg |
| 1641 | ALX-201-314-C010 | COMP (rat):Angiopoietin-1 (human), (recombinant) | 10 µg |
| 1642 | ALX-201-314-C050 | COMP (rat):Angiopoietin-1 (human), (recombinant) | 50 µg |
| 1643 | ALX-201-314-C500 | COMP (rat):Angiopoietin-1 (human), (recombinant) | 500 µg |
| 1644 | ALX-201-325-C050 | RELM-β (mouse), (recombinant) | 50 µg |
| 1645 | ALX-201-332-C050 | Nampt (Visfatin/PBEF) (rat), (recombinant) (His-tag) | 50 µg |
| 1646 | ALX-201-336-C010 | eNampt (Visfatin/PBEF) (human), (recombinant) | 10 µg |
| 1647 | ALX-201-344-C050 | FABP1 (human), (recombinant) (His-tag) | 50 µg |
| 1648 | ALX-201-353-C010 | RBP4 (mouse), (recombinant) | 10 µg |
| 1649 | ALX-201-357-C050 | RBP4 (rat), (recombinant) | 50 µg |
| 1650 | ALX-201-369-C050 | CTRP2 (globular domain) (mouse), (recombinant) | 50 µg |
| 1651 | ALX-201-385-C010 | ANGPTL5 (coiled-coil domain) (human), (recombinant) | 10 µg |
| 1652 | ALX-201-387-C050 | ANGPTL1 (fibrinogen-like domain) (human), (recombinant) | 50 µg |
| 1653 | ALX-201-391-C050 | ANGPTL3 (mouse), (recombinant) | 50 µg |
| 1654 | ALX-201-393-C050 | ANGPTL5 (fibrinogen-like domain) (human), (recombinant) | 50 µg |
| 1655 | ALX-201-395-C010 | ANGPTL7 (fibrinogen-like domain) (human), (recombinant) | 10 µg |
| 1656 | ALX-201-412-C010 | ANGPTL3 (coiled-coil domain) (mouse), (recombinant) (His-tag) | 10 µg |
| 1657 | ALX-201-428-C010 | DNER (extracellular domain) (human):Fc (human), (recombinant) | 10 µg |
| 1658 | ALX-201-451-C010 | CTRP5 (human), (recombinant) (His-tag) | 10 µg |
| 1659 | ALX-201-468-C010 | IL-33 (human) (homeodomain-like helix-turn-helix), (recombinant) (His-tag) | 10 µg |
| 1660 | ALX-201-490-0200 | RBP (human), (native) | 200 µg |
| 1661 | ALX-201-501-0050 | IDO (human), (recombinant) (His-tag) | 50 µg |
| 1662 | ALX-201-502-0050 | Progranulin (human), (recombinant) | 50 µg |
| 1663 | ALX-201-503-0050 | Progranulin (mouse), (recombinant) | 50 µg |
| 1664 | ALX-201-504-0010 | Pro-IL-33 (human), (recombinant) (His-tag) | 10 µg |
| 1665 | ALX-201-750-1 | Hepsin (human), (recombinant) | 125 U |
| 1666 | ALX-201-751-1 | DESC1 (human), (recombinant) | 125 U |
| 1667 | ALX-201-752-0500 | Matriptase-2 (human), (recombinant) | 500 U |
| 1668 | ALX-201-752-1 | Matriptase-2 (human), (recombinant) | 125 U |
| 1669 | ALX-201-761-0010 | Clusterin (secretory form) (human), (recombinant) (His-tag) | 10 µg |
| 1670 | ALX-201-761-0050 | Clusterin (secretory form) (human), (recombinant) (His-tag) | 50 µg |
| 1671 | ALX-201-764-0010 | DLK1 (human), (recombinant) (His-tag) | 10 µg |
| 1672 | ALX-201-764-0050 | DLK1 (human), (recombinant) (His-tag) | 50 µg |
| 1673 | ALX-201-765-0025 | DLL1 (soluble) (human), (recombinant) | 25 µg |
| 1674 | ALX-201-766-0025 | DLL4 (soluble) (human), (recombinant) | 25 µg |
| 1675 | ALX-201-800-0002 | Flt-3 ligand (human), (recombinant) | 2 µg |
| 1676 | ALX-201-800-0010 | Flt-3 ligand (human), (recombinant) | 10 µg |
| 1677 | ALX-201-800-0100 | Flt-3 ligand (human), (recombinant) | 100 µg |
| 1678 | ALX-201-801-0002 | Flt-3 ligand (mouse), (recombinant) | 2 µg |
| 1679 | ALX-201-801-0010 | Flt-3 ligand (mouse), (recombinant) | 10 µg |
| 1680 | ALX-201-801-0100 | Flt-3 ligand (mouse), (recombinant) | 100 µg |
| 1681 | ALX-201-802-0010 | Growth and differentiation factor-5 (human), (recombinant) | 10 µg |
| 1682 | ALX-201-802-0050 | Growth and differentiation factor-5 (human), (recombinant) | 50 µg |
| 1683 | ALX-201-802-0100 | Growth and differentiation factor-5 (human), (recombinant) | 100 µg |
| 1684 | ALX-201-803-0005 | Growth and differentiation factor-15 (human), (recombinant) | 5 µg |
| 1685 | ALX-201-803-0020 | Growth and differentiation factor-15 (human), (recombinant) | 20 µg |
| 1686 | ALX-201-803-0100 | Growth and differentiation factor-15 (human), (recombinant) | 100 µg |
| 1687 | ALX-201-804-0002 | Stem cell factor (human), (recombinant) | 2 µg |
| 1688 | ALX-201-804-0010 | Stem cell factor (human), (recombinant) | 10 µg |
| 1689 | ALX-201-804-0100 | Stem cell factor (human), (recombinant) | 100 µg |
| 1690 | ALX-201-805-0002 | Stem cell factor (mouse), (recombinant) | 2 µg |
| 1691 | ALX-201-805-0010 | Stem cell factor (mouse), (recombinant) | 10 µg |
| 1692 | ALX-201-805-0100 | Stem cell factor (mouse), (recombinant) | 100 µg |
| 1693 | ALX-201-806-0002 | Stem cell factor (rat), (recombinant) | 2 µg |
| 1694 | ALX-201-806-0010 | Stem cell factor (rat), (recombinant) | 10 µg |
| 1695 | ALX-201-806-0100 | Stem cell factor (rat), (recombinant) | 100 µg |
| 1696 | ALX-201-808-0002 | Thrombopoietin (mouse), (recombinant) | 2 µg |
| 1697 | ALX-201-808-0010 | Thrombopoietin (mouse), (recombinant) | 10 µg |
| 1698 | ALX-201-808-0100 | Thrombopoietin (mouse), (recombinant) | 100 µg |
| 1699 | ALX-201-809-0010 | Activin-A (human), (recombinant) | 10 µg |
| 1700 | ALX-201-809-0100 | Activin-A (human), (recombinant) | 100 µg |
| 1701 | ALX-201-812-0100 | Epidermal growth factor (rat), (recombinant) | 100 µg |
| 1702 | ALX-201-813-0020 | Follistatin (human), (recombinant) | 20 µg |
| 1703 | ALX-201-813-0100 | Follistatin (human), (recombinant) | 100 µg |
| 1704 | ALX-201-814-0020 | Follistatin (mouse), (recombinant) | 20 µg |
| 1705 | ALX-201-815-0010 | IL-12 (mouse), (recombinant) | 10 µg |
| 1706 | ALX-201-815-0100 | IL-12 (mouse), (recombinant) | 100 µg |
| 1707 | ALX-201-816-0020 | TARC (human), (recombinant) | 20 µg |
| 1708 | ALX-201-816-0100 | TARC (human), (recombinant) | 100 µg |
| 1709 | ALX-201-817-0010 | TGF-β3 (mouse), (recombinant) | 10 µg |
| 1710 | ALX-201-817-0100 | TGF-β3 (mouse), (recombinant) | 100 µg |
| 1711 | ALX-201-818-0020 | IL-6 (human), (recombinant) | 20 µg |
| 1712 | ALX-201-818-0100 | IL-6 (human), (recombinant) | 100 µg |
| 1713 | ALX-201-819-0010 | IL-6 (mouse), (recombinant) | 10 µg |
| 1714 | ALX-201-819-0100 | IL-6 (mouse), (recombinant) | 100 µg |
| 1715 | ALX-201-820-0010 | IL-3 (human), (recombinant) | 10 µg |
| 1716 | ALX-201-820-0100 | IL-3 (human), (recombinant) | 100 µg |
| 1717 | ALX-201-821-0010 | IL-3 (mouse), (recombinant) | 10 µg |
| 1718 | ALX-201-821-0100 | IL-3 (mouse), (recombinant) | 100 µg |
| 1719 | ALX-201-822-0010 | FGF-basic 147 (human), (recombinant) | 10 µg |
| 1720 | ALX-201-822-0050 | FGF-basic 147 (human), (recombinant) | 50 µg |
| 1721 | ALX-201-822-0100 | FGF-basic 147 (human), (recombinant) | 100 µg |
| 1722 | ALX-201-823-0010 | FGF-basic 154 (human), (recombinant) | 10 µg |
| 1723 | ALX-201-823-0050 | FGF-basic 154 (human), (recombinant) | 50 µg |
| 1724 | ALX-201-823-0100 | FGF-basic 154 (human), (recombinant) | 100 µg |
| 1725 | ALX-201-824-0010 | FGF basic (mouse), (recombinant) | 10 µg |
| 1726 | ALX-201-824-0050 | FGF basic (mouse), (recombinant) | 50 µg |
| 1727 | ALX-201-824-0100 | FGF basic (mouse), (recombinant) | 100 µg |
| 1728 | ALX-201-850-0020 | Angiopoietin-1 (human), (recombinant) | 20 µg |
| 1729 | ALX-201-852-0010 | iNOS (human), (recombinant) (His-tag) | 10 µg |
| 1730 | ALX-201-853-0010 | eNOS (human), (recombinant) | 10 µg |
| 1731 | ALX-201-854-0010 | nNOS (rat), (recombinant) | 10 µg |
| 1732 | ALX-202-022-UT50 | Cu/Zn superoxide dismutase (bovine liver) | 5 kU |
| 1733 | ALX-202-022-UZ50 | Cu/Zn superoxide dismutase (bovine liver) | 50 kU |
| 1734 | ALX-202-024-M001 | Calmodulin (bovine brain), (high purity) | 1 mg |
| 1735 | ALX-202-039-C005 | Guanylyl cyclase (soluble) (bovine lung) | 5 µg |
| 1736 | ALX-202-043-C001 | Poly(ADP-ribose), standard | 1 µg |
| 1737 | ALX-202-045-UC01 | PARG (bovine thymus) | 0.1 U |
| 1738 | ALX-202-052-L002 | HDAC (rat liver) | 2 ml |
| 1739 | ALX-202-062-M001 | Calmodulin (pig brain) | 1 mg |
| 1740 | ALX-202-064-M025 | KLH, (highly soluble) (low endotoxin) | 25 mg |
| 1741 | ALX-202-064-M100 | KLH, (highly soluble) (low endotoxin) | 100 mg |
| 1742 | ALX-202-070-C500 | Metallothionein-1 (rabbit liver), (cell culture grade) | 500 µg |
| 1743 | ALX-202-072-M001 | Metallothionein-1 (rabbit liver) | 1 mg |
| 1744 | ALX-203-001-C020 | Enhancer for Receptors | 20 µg |
| 1745 | ALX-203-002-C010 | ACRP30<i>headless</i> (human), (recombinant) | 10 µg |
| 1746 | ALX-203-003-C010 | ACRP30<i>headless</i> (mouse), (recombinant) | 10 µg |
| 1747 | ALX-203-004-C050 | Control:Fc fusion protein (human), (recombinant) | 50 µg |
| 1748 | ALX-209-001-C050 | Calmodulin (bovine brain), (high purity) (biotin conjugate) | 50 µg |
| 1749 | ALX-209-002-T300 | Annexin V (human), (recombinant) (biotin conjugate) | 300 tests |
| 1750 | ALX-209-250-T020 | Annexin V (human), (recombinant) (FITC conjugate) | 20 tests |
| 1751 | ALX-209-250-T100 | Annexin V (human), (recombinant) (FITC conjugate) | 100 tests |
| 1752 | ALX-209-250-T300 | Annexin V (human), (recombinant) (FITC conjugate) | 300 tests |
| 1753 | ALX-209-251-T020 | Annexin V (human), (recombinant) (R-PE conjugate) | 20 tests |
| 1754 | ALX-209-251-T100 | Annexin V (human), (recombinant) (R-PE conjugate) | 100 tests |
| 1755 | ALX-209-252-T020 | Annexin V (human), (recombinant) (APC conjugate) | 20 tests |
| 1756 | ALX-209-252-T100 | Annexin V (human), (recombinant) (APC conjugate) | 100 tests |
| 1757 | ALX-209-256-3100 | Annexin V (human), (recombinant) (FITC conjugate) | 3 x 100 tests |
| 1758 | ALX-209-256-T100 | Annexin V (human), (recombinant) (FITC conjugate) | 100 tests |
| 1759 | ALX-210-002-R050 | Bak polyclonal antibody | 50 µl |
| 1760 | ALX-210-003-R050 | Bax polyclonal antibody | 50 µl |
| 1761 | ALX-210-004-R050 | Bcl-X<sub>L/S</sub> polyclonal antibody (1695) | 50 µl |
| 1762 | ALX-210-006-R050 | Bid (human) polyclonal antibody (AR-54) | 50 µl |
| 1763 | ALX-210-009-R050 | BAG-1 (mouse) (CT) polyclonal antibody (Bur 1702) | 50 µl |
| 1764 | ALX-210-014-R050 | Caspase-9 polyclonal antibody (Bur 49) | 50 µl |
| 1765 | ALX-210-015-R050 | Caspase-9 polyclonal antibody (Bur 73) | 50 µl |
| 1766 | ALX-210-016-R050 | BAR (human) polyclonal antibody (AR-48) | 50 µl |
| 1767 | ALX-210-017-R050 | NLRP1/NALP1 (human) (CT) polyclonal antibody (Bur 242) | 50 µl |
| 1768 | ALX-210-018-R050 | NLRP1/NALP1 (human) (NT) polyclonal antibody (Bur 241) | 50 µl |
| 1769 | ALX-210-019-R050 | Survivin (human) polyclonal antibody | 50 µl |
| 1770 | ALX-210-020-R050 | FAP-1 (human) polyclonal antibody (1730) | 50 µl |
| 1771 | ALX-210-025-R050 | TRAF3 (human) polyclonal antibody | 50 µl |
| 1772 | ALX-210-026-R050 | TRAF4 (human) polyclonal antibody | 50 µl |
| 1773 | ALX-210-027-R050 | TRAF5 polyclonal antibody (1847) | 50 µl |
| 1774 | ALX-210-029-R050 | TRAF2 (mouse) polyclonal antibody (AR-63) | 50 µl |
| 1775 | ALX-210-065-C050 | mTOR polyclonal antibody | 50 µg |
| 1776 | ALX-210-066-C050 | ATRIP (human) polyclonal antibody | 50 µg |
| 1777 | ALX-210-099-C050 | PDE5A polyclonal antibody | 50 µg |
| 1778 | ALX-210-1037-0100 | Fis1 polyclonal antibody | 100 µg |
| 1779 | ALX-210-105-R050 | Leptin polyclonal antibody | 50 µl |
| 1780 | ALX-210-113-C200 | c-Fos (mouse) polyclonal antibody | 200 µg |
| 1781 | ALX-210-126-R100 | Calreticulin polyclonal antibody | 100 µl |
| 1782 | ALX-210-127-R100 | β-COP polyclonal antibody | 100 µl |
| 1783 | ALX-210-130-C100 | c-Fos polyclonal antibody | 100 µg |
| 1784 | ALX-210-132-C100 | Estrogen receptor β polyclonal antibody | 100 µg |
| 1785 | ALX-210-134-R100 | Furin convertase polyclonal antibody | 100 µl |
| 1786 | ALX-210-135-C050 | Estrogen receptor β polyclonal antibody | 50 µg |
| 1787 | ALX-210-137-C100 | Grp78/Bip polyclonal antibody | 100 µg |
| 1788 | ALX-210-140-R100 | HSP104 polyclonal antibody | 100 µl |
| 1789 | ALX-210-142-R100 | FKBP12 polyclonal antibody | 100 µl |
| 1790 | ALX-210-143-R100 | Ca<sup>2+</sup>-sensing receptor polyclonal antibody | 100 µl |
| 1791 | ALX-210-148-R100 | Adrenergic receptor β-1 polyclonal antibody | 100 µl |
| 1792 | ALX-210-154-R050 | Glucocorticoid receptor β (human) polyclonal antibody | 50 µl |
| 1793 | ALX-210-168-R100 | Leptin receptor polyclonal antibody | 100 µl |
| 1794 | ALX-210-169-R100 | Inositol 1,4,5-trisphosphate receptor (type-I) polyclonal antibody | 100 µl |
| 1795 | ALX-210-170-R100 | Calreticulin (NT) polyclonal antibody | 100 µl |
| 1796 | ALX-210-175-1 | Furin convertase (human) polyclonal antibody | 1 Vial |
| 1797 | ALX-210-178-C050 | Estrogen receptor β polyclonal antibody | 50 µg |
| 1798 | ALX-210-180-C050 | Estrogen receptor β polyclonal antibody | 50 µg |
| 1799 | ALX-210-191-R100 | PPARδ polyclonal antibody | 100 µl |
| 1800 | ALX-210-192-R100 | PPARγ2 (mouse) polyclonal antibody | 100 µl |
| 1801 | ALX-210-199-R100 | Green fluorescent protein polyclonal antibody | 100 µl |
| 1802 | ALX-210-201-C050 | Estrogen receptor α polyclonal antibody | 50 µg |
| 1803 | ALX-210-205-C100 | Peroxisomal membrane protein 70 (mouse) polyclonal antibody | 100 µg |
| 1804 | ALX-210-206-R100 | Lysosome-associated membrane protein-2 polyclonal antibody | 100 µl |
| 1805 | ALX-210-208-R100 | c-Myc epitope tag polyclonal antibody | 100 µl |
| 1806 | ALX-210-227-R200 | Myosin VIIa (mouse) polyclonal antibody | 200 µl |
| 1807 | ALX-210-233-C050 | Ubc9 polyclonal antibody | 50 µg |
| 1808 | ALX-210-239-C100 | Early endosomal antigen 1 polyclonal antibody | 100 µg |
| 1809 | ALX-210-241-C100 | Caveolin-3 polyclonal antibody | 100 µg |
| 1810 | ALX-210-247-C100 | Munc-18 polyclonal antibody | 100 µg |
| 1811 | ALX-210-276-R100 | Cytochrome P450 3A4 polyclonal antibody | 100 µl |
| 1812 | ALX-210-277-C050 | Glucocorticoid receptor α polyclonal antibody | 50 µg |
| 1813 | ALX-210-279-R100 | SNAP-25 polyclonal antibody | 100 µl |
| 1814 | ALX-210-280-R100 | SAP97 polyclonal antibody | 100 µl |
| 1815 | ALX-210-302-R100 | PARP-1 polyclonal antibody | 100 µl |
| 1816 | ALX-210-309-R020 | Osteopontin polyclonal antibody | 20 µl |
| 1817 | ALX-210-309-R100 | Osteopontin polyclonal antibody | 100 µl |
| 1818 | ALX-210-312-R020 | Bone sialoprotein polyclonal antibody | 20 µl |
| 1819 | ALX-210-312-R100 | Bone sialoprotein polyclonal antibody | 100 µl |
| 1820 | ALX-210-314-R100 | Cannabinoid receptor 1 polyclonal antibody | 100 µl |
| 1821 | ALX-210-315-R100 | Cannabinoid receptor 2 polyclonal antibody | 100 µl |
| 1822 | ALX-210-316-R100 | Cannabinoid receptor 1 polyclonal antibody | 100 µl |
| 1823 | ALX-210-327-C100 | XIAP polyclonal antibody | 100 µg |
| 1824 | ALX-210-328-C050 | SUMO-1 activating enzyme subunit SAE1 (human) polyclonal antibody | 50 µg |
| 1825 | ALX-210-333-C100 | Osteocalcin (mouse) (NT) polyclonal antibody | 100 µg |
| 1826 | ALX-210-335-C100 | TNF-α polyclonal antibody | 100 µg |
| 1827 | ALX-210-339-C100 | HDAC4 (NT) polyclonal antibody | 100 µg |
| 1828 | ALX-210-340-C100 | HDAC5 polyclonal antibody | 100 µg |
| 1829 | ALX-210-341-C100 | HDAC6 polyclonal antibody | 100 µg |
| 1830 | ALX-210-351-R400 | Cyclophilin A (human) polyclonal antibody | 400 µl |
| 1831 | ALX-210-356-C050 | α-Actinin-4 polyclonal antibody | 50 µg |
| 1832 | ALX-210-365B-C050 | PTX3 polyclonal antibody (biotin conjugate) | 50 µg |
| 1833 | ALX-210-365-C050 | PTX3 polyclonal antibody | 50 µg |
| 1834 | ALX-210-367-C100 | Toll-like receptor 3 (mouse) polyclonal antibody | 100 µg |
| 1835 | ALX-210-383B-C050 | Leptin (rat) polyclonal antibody (biotin conjugate) | 50 µg |
| 1836 | ALX-210-391-R100 | UBE1L (human) polyclonal antibody | 100 µl |
| 1837 | ALX-210-392-R200 | SOCS-1 polyclonal antibody | 200 µl |
| 1838 | ALX-210-399-C050 | Periostin polyclonal antibody | 50 µg |
| 1839 | ALX-210-404-R100 | ERp29 polyclonal antibody | 100 µl |
| 1840 | ALX-210-425-C100 | Nampt (Visfatin/PBEF) (human) polyclonal antibody | 100 µg |
| 1841 | ALX-210-426-C100 | Nampt (Visfatin/PBEF) (human) (NT) polyclonal antibody | 100 µg |
| 1842 | ALX-210-430-C100 | ANGPTL6 (human) polyclonal antibody | 100 µg |
| 1843 | ALX-210-436-C100 | FOXP3 (mouse) polyclonal antibody | 100 µg |
| 1844 | ALX-210-440-C100 | RBP4 (rat) polyclonal antibody | 100 µg |
| 1845 | ALX-210-442-C100 | FABP4 (human) polyclonal antibody | 100 µg |
| 1846 | ALX-210-473-C100 | ANGPTL5 (coiled-coil domain) (human) polyclonal antibody | 100 µg |
| 1847 | ALX-210-482-C100 | SENP2 (mouse) polyclonal antibody | 100 µg |
| 1848 | ALX-210-483-C100 | DLL1 (human) polyclonal antibody | 100 µg |
| 1849 | ALX-210-504-R100 | Nitric oxide synthase (inducible) (mouse) polyclonal antibody | 100 µl |
| 1850 | ALX-210-505-R100 | Nitric oxide synthase (endothelial) polyclonal antibody | 100 µl |
| 1851 | ALX-210-507A-C250 | Endothelin A receptor polyclonal antibody | 250 µg |
| 1852 | ALX-210-509-R100 | Nitric oxide synthase (endothelial) polyclonal antibody | 100 µl |
| 1853 | ALX-210-517-R100 | PACE4 (human) polyclonal antibody | 100 µl |
| 1854 | ALX-210-529-C100 | Nitric oxide synthase (neuronal) polyclonal antibody | 100 µg |
| 1855 | ALX-210-535-R100 | Shc polyclonal antibody | 100 µl |
| 1856 | ALX-210-537-R100 | CD51 polyclonal antibody | 100 µl |
| 1857 | ALX-210-539-R100 | XRCC1 (human) polyclonal antibody | 100 µl |
| 1858 | ALX-210-540-R100 | PARP-1 (BRCT Domain) polyclonal antibody | 100 µl |
| 1859 | ALX-210-551-R100 | O<sup>6</sup>-Methylguanine-DNA methyltransferase polyclonal antibody | 100 µl |
| 1860 | ALX-210-553-R100 | DNA polymerase β polyclonal antibody | 100 µl |
| 1861 | ALX-210-567-C100 | PAG/Cbp polyclonal antibody | 100 µg |
| 1862 | ALX-210-569-C100 | DR6 (human) polyclonal antibody | 100 µg |
| 1863 | ALX-210-574-R100 | NF-κB (p65) polyclonal antibody | 100 µl |
| 1864 | ALX-210-578-C020 | NF-ATc2 polyclonal antibody | 20 µg |
| 1865 | ALX-210-579-C100 | PAG/Cbp polyclonal antibody | 100 µg |
| 1866 | ALX-210-618-C400 | N-cadherin polyclonal antibody | 400 µg |
| 1867 | ALX-210-619-R100 | PARP-1 (mouse) polyclonal antibody | 100 µl |
| 1868 | ALX-210-621-C200 | CCR4 (mouse) polyclonal antibody | 200 µg |
| 1869 | ALX-210-622-C200 | CCR4 (human) polyclonal antibody | 200 µg |
| 1870 | ALX-210-636-C200 | IL-23 receptor polyclonal antibody | 200 µg |
| 1871 | ALX-210-637-C200 | Toll-like receptor 9 (mouse) polyclonal antibody | 200 µg |
| 1872 | ALX-210-638-C200 | Toll-like receptor 4 polyclonal antibody | 200 µg |
| 1873 | ALX-210-641-C200 | CCR3 (mouse) polyclonal antibody | 200 µg |
| 1874 | ALX-210-645-C200 | Adiponectin receptor 1 polyclonal antibody | 200 µg |
| 1875 | ALX-210-646-C200 | Adiponectin receptor 2 (human) polyclonal antibody | 200 µg |
| 1876 | ALX-210-647-C200 | Adiponectin receptor 2 (mouse) polyclonal antibody | 200 µg |
| 1877 | ALX-210-723-R100 | Apurinic/apyrimidinic endonuclease polyclonal antibody | 100 µl |
| 1878 | ALX-210-732-R100 | TRAIL (human) polyclonal antibody | 100 µl |
| 1879 | ALX-210-742-R100 | CCR4 (mouse) polyclonal antibody | 100 µl |
| 1880 | ALX-210-743-C200 | TRAIL-R2 polyclonal antibody | 200 µg |
| 1881 | ALX-210-744-C200 | TRAIL-R3 (human) polyclonal antibody | 200 µg |
| 1882 | ALX-210-747-C200 | Phosphoinositide 3-kinase p110δ (human) polyclonal antibody | 200 µg |
| 1883 | ALX-210-753-R500 | MMP-2 polyclonal antibody | 500 µl |
| 1884 | ALX-210-756-C100 | MMP-9 polyclonal antibody | 100 µg |
| 1885 | ALX-210-762-C200 | CCR8 (human) (NT) polyclonal antibody | 200 µg |
| 1886 | ALX-210-764-C100 | CCR8 (human) polyclonal antibody | 100 µg |
| 1887 | ALX-210-785-C100 | Voltage-dependent anion channel polyclonal antibody | 100 µg |
| 1888 | ALX-210-786-R100 | Guanylyl cyclase α<sub>1</sub>β<sub>1</sub> (soluble) polyclonal antibody | 100 µl |
| 1889 | ALX-210-788-C100 | Smac/DIABLO (human) polyclonal antibody | 100 µg |
| 1890 | ALX-210-789-C100 | Cyclophilin D polyclonal antibody | 100 µg |
| 1891 | ALX-210-792-C100 | VAMP-2 polyclonal antibody | 100 µg |
| 1892 | ALX-210-798-R100 | ATR (human) polyclonal antibody | 100 µl |
| 1893 | ALX-210-799-C100 | BAFF (CT) polyclonal antibody | 100 µg |
| 1894 | ALX-210-800-C100 | TACI polyclonal antibody | 100 µg |
| 1895 | ALX-210-801-C100 | Troy polyclonal antibody | 100 µg |
| 1896 | ALX-210-802-R100 | 8-Hydroxyguanosine polyclonal antibody | 100 µl |
| 1897 | ALX-210-804-C100 | Caspase-1 polyclonal antibody | 100 µg |
| 1898 | ALX-210-806-C100 | Caspase-3 polyclonal antibody | 100 µg |
| 1899 | ALX-210-807-C100 | Caspase-3 (active) polyclonal antibody | 100 µg |
| 1900 | ALX-210-815-C100 | Caspase-9 polyclonal antibody | 100 µg |
| 1901 | ALX-210-816-C100 | Caspase-9 (active) polyclonal antibody | 100 µg |
| 1902 | ALX-210-818-C100 | Caspase-11 polyclonal antibody | 100 µg |
| 1903 | ALX-210-819-C200 | CXCR4 (mouse) polyclonal antibody | 200 µg |
| 1904 | ALX-210-821-C200 | CCR2 (human) polyclonal antibody | 200 µg |
| 1905 | ALX-210-823-C200 | CCR5 (human) polyclonal antibody | 200 µg |
| 1906 | ALX-210-833-R100 | MMP-13 (human) polyclonal antibody | 100 µl |
| 1907 | ALX-210-838-R100 | Caspase-9 (human) polyclonal antibody | 100 µl |
| 1908 | ALX-210-843-C200 | CCR6 polyclonal antibody | 200 µg |
| 1909 | ALX-210-844-C100 | CCR7 polyclonal antibody | 100 µg |
| 1910 | ALX-210-845-C200 | CCR8 (mouse) polyclonal antibody | 200 µg |
| 1911 | ALX-210-847-C200 | CCR9 (human) polyclonal antibody | 200 µg |
| 1912 | ALX-210-853-C200 | Toll-like receptor 5 (human) polyclonal antibody | 200 µg |
| 1913 | ALX-210-856-R200 | MRP4 (human) polyclonal antibody | 200 µl |
| 1914 | ALX-210-865-R200 | SENP5 polyclonal antibody | 200 µl |
| 1915 | ALX-210-874-C100 | Toll-like receptor 7 polyclonal antibody | 100 µg |
| 1916 | ALX-210-874F-C100 | Toll-like receptor 7 polyclonal antibody (FITC conjugate) | 100 µg |
| 1917 | ALX-210-876-C100 | MMP-1 polyclonal antibody | 100 µg |
| 1918 | ALX-210-879-R100 | Malondialdehyde polyclonal antibody | 100 µl |
| 1919 | ALX-210-880-C025 | VASP polyclonal antibody (affinity purified) | 25 µg |
| 1920 | ALX-210-889-R100 | PDIA6 (human) polyclonal antibody | 100 µl |
| 1921 | ALX-210-895-R100 | PARP-1 (human) polyclonal antibody | 100 µl |
| 1922 | ALX-210-898-R100 | VASP (human) polyclonal antibody | 100 µl |
| 1923 | ALX-210-899-R100 | PARP-2 (mouse) polyclonal antibody | 100 µl |
| 1924 | ALX-210-900-R100 | MyD88 polyclonal antibody | 100 µl |
| 1925 | ALX-210-904-R100 | NLRP1/NALP1 (human) polyclonal antibody (AL176) | 100 µl |
| 1926 | ALX-210-911-C100 | NM23-H1 polyclonal antibody (K73) | 100 µg |
| 1927 | ALX-210-912-C100 | PRUNE (human) polyclonal antibody (A59) | 100 µg |
| 1928 | ALX-210-913-R100 | Adiponectin receptor 1 (human) polyclonal antibody (AL238) | 100 µl |
| 1929 | ALX-210-914-R050 | TRAM (human) polyclonal antibody (AL239) | 50 µl |
| 1930 | ALX-210-915-C050 | RAIDD (human) polyclonal antibody (AT100) | 50 µg |
| 1931 | ALX-210-916-R100 | Adiponectin receptor 2 (mouse) polyclonal antibody (AL241) | 100 µl |
| 1932 | ALX-210-918-C050 | Nod1 (human) polyclonal antibody (AL184) | 50 µg |
| 1933 | ALX-210-922-C050 | Cornulin (human) polyclonal antibody (SZ1229) | 50 µg |
| 1934 | ALX-210-926-C050 | TWEAK polyclonal antibody (AT104) | 50 µg |
| 1935 | ALX-210-928-C100 | LRRK2 (human) polyclonal antibody (AT106) | 100 µg |
| 1936 | ALX-210-929-C100 | Cardif (human) polyclonal antibody (AT107) | 100 µg |
| 1937 | ALX-210-932-C100 | RIG-I (human) polyclonal antibody (AT111) | 100 µg |
| 1938 | ALX-210-933B-C100 | IL-33 polyclonal antibody (AT110) (biotin conjugate) | 100 µg |
| 1939 | ALX-210-933-C100 | IL-33 polyclonal antibody (AT110) | 100 µg |
| 1940 | ALX-210-935-C100 | MDA5 (human) polyclonal antibody (AT113) | 100 µg |
| 1941 | ALX-210-936-C100 | CTRP5 (mouse) polyclonal antibody (AT114) | 100 µg |
| 1942 | ALX-210-943-C100 | Netrin-1 polyclonal antibody (AT118) | 100 µg |
| 1943 | ALX-210-945B-C100 | Osteoprotegerin (human) polyclonal antibody (AT121) (biotin conjugate) | 100 µg |
| 1944 | ALX-210-945-C100 | Osteoprotegerin (human) polyclonal antibody (AT121) | 100 µg |
| 1945 | ALX-210-948-C100 | ILEI polyclonal antibody (AT123) | 100 µg |
| 1946 | ALX-210-949-C100 | Pannexin-1 (human) polyclonal antibody (AT124) | 100 µg |
| 1947 | ALX-210-950-C100 | APRIL (membrane form) (human) polyclonal antibody (AT125) | 100 µg |
| 1948 | ALX-210-952-C100 | TL1A polyclonal antibody (AT127) | 100 µg |
| 1949 | ALX-210-953B-C100 | Netrin-4 polyclonal antibody (AT128) (biotin conjugate) | 100 µg |
| 1950 | ALX-210-953-C100 | Netrin-4 polyclonal antibody (AT128) | 100 µg |
| 1951 | ALX-210-955-C100 | WIPI-1 polyclonal antibody (AT130) | 100 µg |
| 1952 | ALX-210-956-C100 | Viperin polyclonal antibody (AT131) | 100 µg |
| 1953 | ALX-210-958-C100 | NLRP12/NALP12 polyclonal antibody (human) (AL236) | 100 µg |
| 1954 | ALX-210-959-C100 | ZBP1 (human) polyclonal antibody (AT133) | 100 µg |
| 1955 | ALX-210-961-C100 | AROS (human) polyclonal antibody (AT135) | 100 µg |
| 1956 | ALX-210-962-C100 | Epstein-Barr Virus-induced Gene 3 (human) polyclonal antibody (AT136) | 100 µg |
| 1957 | ALX-210-963-C050 | LGP2 (human) polyclonal antibody (AT137) | 50 µg |
| 1958 | ALX-210-967-C100 | NLRP12/NALP12 (mouse) polyclonal antibody (AT141) | 100 µg |
| 1959 | ALX-210-968-C100 | Meteorin (human) polyclonal antibody (AT142) | 100 µg |
| 1960 | ALX-210-971-R100 | PARP-3 polyclonal antibody | 100 µl |
| 1961 | ALX-210-974-0100 | RBP4 polyclonal antibody | 100 µg |
| 1962 | ALX-211-056-C050 | Goat anti-rat IgM (rat Ig adsorbed), (R-PE conjugate) | 50 µg |
| 1963 | ALX-211-204TM-C100 | Goat anti-mouse IgG1 (human & mouse Ig adsorbed), (ATTO 590 conjugate) | 100 µg |
| 1964 | ALX-215-001-R100 | [pSer<sup>262</sup>]Tau polyclonal antibody | 100 µl |
| 1965 | ALX-215-005-C100 | HSP47 (human) polyclonal antibody | 100 µg |
| 1966 | ALX-215-016-R200 | TRIF polyclonal antibody | 200 µl |
| 1967 | ALX-215-033-R100 | Purinergic receptor P2X4 (mouse) polyclonal antibody | 100 µl |
| 1968 | ALX-215-034-R100 | Purinergic receptor P2X4 (human) polyclonal antibody | 100 µl |
| 1969 | ALX-215-035-R100 | Purinergic receptor P2X7 (mouse) polyclonal antibody | 100 µl |
| 1970 | ALX-215-044-R100 | CD39L1 (mouse) polyclonal antibody | 100 µl |
| 1971 | ALX-215-045-R100 | CD39L1 (human) polyclonal antibody | 100 µl |
| 1972 | ALX-215-049-R100 | HERG1 (CT) (pan) polyclonal antibody | 100 µl |
| 1973 | ALX-215-050-R100 | HERG1A (NT) polyclonal antibody | 100 µl |
| 1974 | ALX-215-051-R100 | HERG1B polyclonal antibody | 100 µl |
| 1975 | ALX-215-052-R100 | HERG2 polyclonal antibody | 100 µl |
| 1976 | ALX-215-057-R050 | [pSer<sup>282</sup>]Myosin-binding protein C (cardiac type) polyclonal antibody | 50 µl |
| 1977 | ALX-215-063-C100 | MD-2 polyclonal antibody | 100 µg |
| 1978 | ALX-215-065-1 | mTOR (human FRB Domain) polyclonal antibody | 1 Vial |
| 1979 | ALX-215-066-R100 | Dimethylargininase-1 polyclonal antibody | 100 µl |
| 1980 | ALX-215-067-R050 | LOXL4 (human) polyclonal antibody | 50 µl |
| 1981 | ALX-215-068-C200 | Vacuole membrane protein 1 polyclonal antibody | 200 µg |
| 1982 | ALX-250-001-M050 | 4-Aminophenylphosphate . sodium salt | 50 mg |
| 1983 | ALX-250-001-M100 | 4-Aminophenylphosphate . sodium salt | 100 mg |
| 1984 | ALX-260-003-M001 | Amastatin . hydrochloride | 1 mg |
| 1985 | ALX-260-003-M005 | Amastatin . hydrochloride | 5 mg |
| 1986 | ALX-260-005-M005 | Chymostatin | 5 mg |
| 1987 | ALX-260-007-M005 | E-64 | 5 mg |
| 1988 | ALX-260-007-M025 | E-64 | 25 mg |
| 1989 | ALX-260-009-M005 | Leupeptin (synthetic) | 5 mg |
| 1990 | ALX-260-009-M025 | Leupeptin (synthetic) | 25 mg |
| 1991 | ALX-260-009-M100 | Leupeptin (synthetic) | 100 mg |
| 1992 | ALX-260-012-M005 | Bestatin . hydrochloride | 5 mg |
| 1993 | ALX-260-013-M005 | Diprotin B | 5 mg |
| 1994 | ALX-260-016-M001 | Ac-YVAD-2,6-dimethylbenzoyloxymethylketone | 1 mg |
| 1995 | ALX-260-016-M005 | Ac-YVAD-2,6-dimethylbenzoyloxymethylketone | 5 mg |
| 1996 | ALX-260-017-M001 | CA-074 | 1 mg |
| 1997 | ALX-260-019-M001 | Biotinyl-YVAD-CMK | 1 mg |
| 1998 | ALX-260-019-M005 | Biotinyl-YVAD-CMK | 5 mg |
| 1999 | ALX-260-020-M001 | Z-VAD-FMK | 1 mg |
| 2000 | ALX-260-020-M005 | Z-VAD-FMK | 5 mg |